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Abstract 
Programmed cell death protein 4 (PDCD4) inhibits IRES-mediated translation of anti-
apoptotic proteins such as XIAP. PDCD4 was shown to directly interact with the XIAP 
IRES element and inhibit translation initiation. Additionally, our lab reported that a 
eukaryotic initiation factor, eIF3 interacts with the XIAP IRES to facilitate ribosome 
recruitment. Interestingly, the activity of PDCD4 and eIF3 are regulated by common 
regulatory kinases called S6K1 and 2. Therefore, to investigate the possibility of 
interaction between PDCD4 and eIF3 as well as their co-regulation by S6K1 and 2, I have 
performed co-immunoprecipitation assays in glioblastoma and S6K double knockout 
MEFs. The results of in cellulo assays demonstrate RNA-independent PDCD4-eIF3 
interactions. In addition, eIF3F, one of the 13 eIF3 subunits has been demonstrated to 
interact directly with PDCD4. This study suggests that the interaction of PDCD4 with 
eIF3F may have a role in regulating global and/or transcript-specific translation.  
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Chapter 1 
Introduction 
In this chapter, I have described eukaryotic translation initiation and the different types of 
initiation mechanisms. I have also discussed the regulatory mechanisms and factors 
affecting translation initiation and their downstream effects on cell survival. To conclude, 
I have described my hypothesis and research plan. 
 
1.1 Description of eukaryotic translation initiation 
The genetic information stored in the double-stranded deoxyribonucleic acid (dsDNA) is 
transcribed into the messenger ribonucleic acid (mRNA) by enzymes called RNA 
polymerases (Kireeva, Kashlev, & Burton, 2013). These enzymes utilize the DNA as a 
template to synthesize complementary mRNA by a process called transcription. In 
eukaryotes, the mRNA is synthesized as precursor mRNA that is processed by the 
addition of  a 7-methylguanosine cap structure onto the 5’ end of the mRNA (capping), 
addition of polyadenosine onto the 3’ end of the mRNA (polyadenylation) and removal of 
introns (splicing) to form mature mRNA (Halbeisen, Galgano, Scherrer, & Gerber, 2008). 
The mature mRNA is transported into the cytoplasm. In the cytoplasm, the translation 
machinery utilizes the mRNA as a template to synthesize proteins by a process called 
translation. Translation is divided into three steps, which occur in the order of initiation, 
elongation, and termination (Hinnebusch & Lorsch, 2012; R. J. Jackson, Hellen, & 
Pestova, 2010). Translation initiation is the most regulated and rate-limiting step of the 
three. The process requires about 12 eukaryotic initiation factors (eIFs), cellular proteins 
(also called trans-acting factors), mature mRNA, ribosomal subunits and initiator transfer 
RNA (tRNAi). The process of initiation is further classified into three steps i) 43S pre-
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initiation complex ii) 48S pre-initiation complex, and iii) 80S pre-initiation complex 
formation. With the assembly of the 80S pre-initiation complex, the ribosome is prepared 
to move into the next step of translation and begin protein synthesis (Hinnebusch & 
Lorsch, 2012; R. J. Jackson et al., 2010). 
In eukaryotes, the translation initiation process is broadly classified into canonical and 
non-canonical initiation. In canonical translation initiation, the 5’ cap structure of the 
mRNA plays an essential role to begin protein synthesis. Alternatively, in non-canonical 
translation, the 5’ cap structure is no longer essential and the translation machinery can be 
recruited onto the mRNA without the involvement of a 5’ cap or initiation factors 
interacting with the cap structure. 
1.1.1 Cap-dependent translation initiation 
Most eukaryotic mRNAs are translated by canonical or cap-dependent translation 
initiation mechanism (Figure 1.1). In this process, it utilizes a set of about 12 eIFs to 
initiate translation. eIF2 is one of the 12 eIFs required for the cap-dependent translation 
and it consists of 3 distinct subunits (eIF2α, eIF2β, and eIF2γ). eIF2 directly interacts 
with guanosine triphosphate (GTP) and initiator met-tRNAi to form the ternary complex 
(Figure 1.1) (Asano, Clayton, Shalev, & Hinnebusch, 2000; Kimball, 1999). Specifically, 
the eIF2γ subunit interacts with GTP, while eIF2β and eIF2γ have regions interacting to 
the met-tRNAi (Kimball, 1999). The active ternary complex then positions the initiator 
met-tRNAi to the P site of the 40S ribosomal subunit associated with eIF3, eIF1A, and 
eIF1 (R. J. Jackson et al., 2010; Maag, Fekete, Gryczynski, & Lorsch, 2005). The ternary 
complex interacts with the 40S ribosomal subunit associated with eIF3, eIF1, and eIF1A 
to form the 43S pre-initiation complex (Figure 1.1). Separately, eIF4B and eIF4F 
complex interact with the mRNA (Figure 1.1) (R. J. Jackson et al., 2010; Maduzia, 
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Moreau, Poullet, Chaffre, & Zhang, 2010). eIF4F is a cap-binding complex and is 
composed of eIF4E, eIF4A and eIF4G. eIF4E is the cap-binding protein that interacts 
with modified guanosine present on the 5’ end of mRNA, eIF4A is a helicase that helps in 
unwinding of secondary structures present on the mRNA and facilitates scanning of 
mRNA by the ribosome, and eIF4G acts as the scaffold protein enabling protein-protein 
interaction between eIF4G and other eIFs such as eIF4G, eIF4E, and eIF3 (Andreev et al., 
2017; R. J. Jackson et al., 2010). eIF4F bound mRNA complex associates with the 43S 
pre-initiation complex (Figure 1.1). This interaction is mediated by eIF3 present in the 
43S pre-initiation complex and eIF4G of the eIF4F-complex (Hinnebusch & Lorsch, 
2012). At this stage, the translation machinery is referred to as an open conformation. 
Upon interaction of mRNA and the 40S ribosome, eIF1 works along with eIF1A to 
support ribosome scanning in order to recognize the start AUG codon (Maduzia et al., 
2010). The complex to is believed to scan the mRNA in the 5’ to 3’ direction to locate the 
initiation codon (Hinnebusch & Lorsch, 2012). When the first start codon (AUG) in the 
context of Kozak sequence is recognized by the translation initiation complex, eIF5 
promotes the GTPase activity of eIF2 to release the eIFs form the 48S pre-initiation 
complex (Figure 1.1). After the release of eIFs from the complex, eIF5B helps the joining 
of the 60S subunit to the smaller ribosomal subunit takes place as mentioned in 
Figure 1.1. This forms the 80S pre-initiation complex and initiates translation elongation  
(Figure 1.1) (R. J. Jackson et al., 2010). At the end of translation, ribosomal subunits are 
dissociated by the function of eukaryotic release factors (Dever & Green, 2012). The 
molecules involved in translation are recycled and fed back into the next round of the 
translation cycle. The cycle of translation is an energy consuming process and hence it is 
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essential for the cells to regulate this mechanism and control the expression of all cellular 
proteins. 
 
Figure 1.1: Schematic representation of cap-dependent translation initiation. met-tRNAi-
eIF2-GTP form the ternary complex, and this complex interacts with the 40S ribosomal 
subunit (associated with eIF3, eIF1, and eIF1A) to form the 43S pre-initiation complex. 
The mRNA associated with the eIF4F complex interacts with the 43S pre-initiation 
48S pre-initiation complex
43S pre-initiation complex
Ternary complex
40S ribosomal subunit, eIF1A and eIF3 
Open conformation
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complex. The complex scans mRNA in the 5’ to 3’ direction, and when met-tRNAi is 
delivered into the P site of the ribosome, it is called the 48S pre-initiation complex. 
Following this event, eIF5 induces GTP hydrolysis by eIF2. Upon the GTP hydrolysis, 
eIFs that are associated with the complex is released. This then leads to the joining of the 
60S ribosomal subunit to the 40S ribosomal to initiate translation. The figure was adapted 
from Sharma D.K et al, Role of eukaryotic initiation factors during cellular stress and 
cancer progression, Journal of Nucleic Acids (2016). 
 
1.1.2 Cap-independent translation initiation 
During stress conditions, eIFs required for cap-dependent translation can undergo post-
translational modification or proteolytic cleavage. As a result of the cleavage, they are 
unavailable to form an active initiation complex and hence attenuate canonical translation 
initiation (Komar & Hatzoglou, 2011; Marissen, Gradi, Sonenberg, & Lloyd, 2000). In 
such conditions, the cell switches from the cap-dependent to a cap-independent mode of 
translation initiation. A cap-independent mechanism of translation initiation can utilize a 
subset of eIFs and IRES trans-acting factors (ITAFs) to recruit the ribosome and to form 
an active initiation complex (Komar & Hatzoglou, 2011). 
During non-canonical translation, the mRNA sequence and/or structure is recognized by a 
subset of eIFs and ITAFs. The interaction of the subset of eIFs and ITAFs with the 
mRNA helps in the ribosome recruitment without the involvement of 5’ cap structure. 
Such RNA structure and sequences are termed as cis-acting elements. Some of the well-
characterized cis-acting elements are internal ribosome entry site (IRES), upstream open 
reading frames and cap-independent translation enhancers (Komar & Hatzoglou, 2011; 
Morris & Geballe, 2000; Terenin, Andreev, Dmitriev, & Shatsky, 2013). Of the different 
types of non-canonical translation mechanisms, IRES-mediated translation is well 
characterized and is explained in the later part of this section. 
  
6 
 
1.1.2.1 Significance of cap-independent translation  
During physiological stress conditions such as hypoxia, DNA damage, nutritional 
deprivation or viral infection, downstream cellular pathways are activated. Stress inducers 
can be an external factor or internally induced in the cell (Fulda, Gorman, Hori, & 
Samali, 2010). Nutritional deprivation, hypoxia (oxygen deficiency), and viral infection 
are categorized as external inducers. On the other hand, DNA damage, imbalance in 
calcium homeostasis, and increase in reactive oxygen species are classified as internal 
inducers (Krampe & Al-Rubeai, 2010; Liang et al., 2017; Pugh, Gleadle, & Maxwell, 
2001; Xu, Bailly-Maitre, & Reed, 2005). In presence of the internal stress inducers or 
external stress inducers, downstream cellular pathways are activated. For example, when 
DNA is damaged due to the stress inducers (e.g. oxidative stress or DNA damaging 
agent), cellular DNA damage response is activated (S. P. Jackson & Bartek, 2009). As a 
result of this response, an increased expression of the p53 protein and its downstream 
target p21 is observed. Increased levels of the p53 and p21 proteins promote cell cycle 
arrest (Benchimol, 2001). The cell cycle arrest aids the DNA repair mechanism (Branzei 
& Foiani, 2008). In case of a failure in the DNA repair mechanism, p53 activates the gene 
expression of proteins such as Bax and PUMA to promote cell death (Benchimol, 2001). 
However, the function of p53 can be inhibited by Murine double minute 2 (MDM2) to 
promote cell survival (Nag, Qin, Srivenugopal, Wang, & Zhang, 2013). Thus, the 
determining factor of cell status is the dominating active protein pool of the cell. If the 
proteins that are a part of a pro-survival pathway are predominantly expressed, the cell 
survives or continues to proliferate. If not, the cell is inclined towards the cell death 
mechanism. Hence, regulation of protein translation plays a critical role in deciding the 
cell fate during stress conditions. Interestingly, during stress conditions, the cap-
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dependent translation is compromised by cleavage or unavailability of eIFs (Choo, Yoon, 
Kim, Roux, & Blenis, 2008; Haghighat et al., 1996; Showkat, Beigh, & Andrabi, 2014). 
As mentioned later in the sections 1.1.2.2 and 1.4, when the cell death pathways are 
activated, it affects the eIF4F cap-binding complex which is crucial for canonical 
translation. In the absence of a mitogenic stimulation, eIF4E-binding protein (4E-BP) 
interacts with eIF4E and inhibits its association with eIF4G, thus interrupting the cap-
binding complex formation (Choo et al., 2008; Showkat et al., 2014). On the other hand, 
when a pro-survival/pro-growth pathway such as the mammalian target of rapamycin 
(mTOR) is activated it results in phosphorylation of 4E-BP and dissociation of 4E-BP 
from eIF4E to promote cap binding activity (Choo et al., 2008; Showkat et al., 2014). 
Thus, these data suggest that external stimuli leading to hyperphosphorylation or 
hypophosphorylation of 4E-BP regulate the efficiency of cap-dependent translation. 
During physiological stress conditions such as DNA damage or hypoxia, programmed 
cell death is induced and as a result, cysteine-aspartic proteases (caspases) are activated. 
Caspases are endoproteases designed to systematically cleave downstream target proteins 
(McIlwain, Berger, & Mak, 2013). Stress-activated executioner caspases cleave eIF4G by 
various mechanisms to inhibit canonical (cap-dependent) translation initiation. Moreover, 
global translation can also be inhibited by eIF2α phosphorylation. During viral infection, 
amino acid starvation, nutritional deprivation, and endoplasmic reticulum (ER) stress 
conditions, protein kinases such as heme-regulated inhibitor kinase, general control 
nonderepressible 2, protein kinase R (PKR), or PKR-like ER kinase (PERK) are 
activated. Any of these activated kinases can phosphorylate eIF2α subunit to decrease the 
availability of the ternary complex and attenuate canonical translation (Clemens, 2001; 
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Komar & Hatzoglou, 2011; Rojas, Arias, & Lopez, 2010; R. Yang, Wek, & Wek, 2000). 
In such conditions, when the cap-dependent translation is compromised, the cell 
transitions from cap-dependent translation to a cap-independent mode of translation to 
synthesize a subset of proteins (Lacerda, Menezes, & Romao, 2017). Many of the cell fate 
regulating mRNAs that code for growth factors, oncogenes, RNA-binding proteins, heat 
shock proteins, tumor suppressors, cyclins, translation factors and apoptosis-related genes 
can be translated by a cap-independent mechanism (Lacerda et al., 2017). For example, in 
response to genotoxic stress, the level of a tumor suppressor protein p53 is increased 
(Walters & Thompson, 2016). The increase in p53 protein level is attributed to the 
increased protein stability and p53 mRNA translation (Walters & Thompson, 2016). Also, 
many of the p53 isoforms that have a pro-apoptotic role are translated by a cap-
independent mechanism (Ray, Grover, & Das, 2006; Walters & Thompson, 2016). This is 
also demonstrated by point mutation in the IRES element that decreased p53 expression 
in comparison to wild-type in the presence of a DNA damaging agent (Grover, 
Sharathchandra, Ponnuswamy, Khan, & Das, 2011). This mechanism of translation is 
fairly common as many mRNAs coding for proteins such as c-Jun, B-cell lymphoma 
extra-large (Bcl-xL), X-linked inhibitor of apoptosis (XIAP), and cellular inhibitor of 
apoptosis protein 1 (cIAP1) utilize an IRES element in the 5’ UTR for translation 
initiation (Graber, Baird, Kao, Mathews, & Holcik, 2010; Holcik & Korneluk, 2000; 
Sherrill, Byrd, Van Eden, & Lloyd, 2004; Walters & Thompson, 2016). The oncoprotein 
c-Jun is known to function as a transcription factor by affecting the expression of cell 
cycle regulators and tumor suppressors. c-Jun protein levels are increased in cancer cells 
without any evidence of a corresponding increase in transcription of c-Jun mRNA. Hence, 
the increased protein levels are correlated to an increase in IRES-mediated translation of 
9 
 
c-Jun mRNA (Walters & Thompson, 2016). Moreover, IRES-mediated translation of 
anti-apoptotic proteins such as Bcl-xL, XIAP, and cIAP1 is responsible for the decreased 
apoptotic cell death (Graber et al., 2010; Holcik & Korneluk, 2000; Sherrill et al., 2004). 
These examples further highlight the importance of cap-independent translation or IRES-
mediated translation during stress conditions and apoptosis. In general, the cap-dependent 
translation is more efficient than a cap-independent translation (Thompson, 2012). 
However, IRES-mediated translation has an advantage during stress conditions 
(Thompson, 2012). 
1.1.2.2 Discovery and classification of IRESes 
IRESes were initially discovered in viruses that are a part of the family picornaviridae 
(Martinez-Salas, Francisco-Velilla, Fernandez-Chamorro, Lozano, & Diaz-Toledano, 
2015; Pelletier & Sonenberg, 1988). Poliovirus and foot-and-mouth disease virus belong 
to this family. The genomes of the latter two viruses encode proteases that cleave eIF4G 
upon infection (Belsham, McInerney, & Ross-Smith, 2000; Novoa & Carrasco, 1999). 
They also increase 4E-BP activity upon infection resulting in enhanced 4E-BP and eIF4E 
association and inhibition of eIF4F complex formation (Gingras, Svitkin, Belsham, Pause, 
& Sonenberg, 1996). As a result, translation of cellular mRNAs is affected, but not the 
viral mRNA translation. These observations where the viruses utilized the eukaryotic 
translation machinery in the absence of cap-binding complex led to the discovery of the 
IRES-mediated translation initiation of the viral genome (Hellen & Sarnow, 2001; 
Pelletier & Sonenberg, 1988). Following this, IRES elements were identified in cellular 
mRNAs. mRNA coding for immunoglobulin heavy chain binding protein was the first 
cellular IRES to be discovered (Hellen & Sarnow, 2001; Sarnow, 1989). After this 
discovery, extensive studies have been conducted to identify the eukaryotic mRNAs 
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containing IRES elements. Recent studies using a high throughput bicistronic assay 
indicated that about 10% of the total eukaryotic cellular mRNAs do have IRES elements 
(Weingarten-Gabbay et al., 2016). 
Based on the RNA sequence and structural similarities, viral IRESes are classified into 
four types (Hellen & Sarnow, 2001; R. J. Jackson et al., 2010). IRES elements present in 
the picornavirus mRNA are classified into type I IRES (e.g. poliovirus) or type II IRES 
(e.g. encephalomyocarditis virus). Hepatitis C virus (HCV) like IRES element and similar 
IRES elements are classified into type III IRES. Lastly, dicistrovirus intergenic regions 
IRES elements (e.g. cricket paralysis virus) are classified as type IV IRES (Gross et al., 
2017; Jaafar, Oguro, Nakamura, & Kieft, 2016; R. J. Jackson et al., 2010; Martinez-Salas, 
Pacheco, Serrano, & Fernandez, 2008; Sweeney, Abaeva, Pestova, & Hellen, 2014). Type 
I and type II IRESes elements do not require eIF4E but do require eIF4G and eIF4A for 
translation initiation (Martinez-Salas et al., 2008). The picornaviruses code for proteases 
that cleave eIF4G and utilize the cleaved part of eIF4G for translation initiation (Hellen & 
Sarnow, 2001). Type III or HCV-like IRESes can directly recruit the ribosome onto an 
mRNA without the involvement of eIF4F, eIF4B, eIF1, and eIF1A. In type IV IRESes, 
initiation can occur in the absence of all eIFs and initiator tRNA (Hellen & Sarnow, 2001; 
R. J. Jackson et al., 2010). Contrarily to viral IRESes, cellular IRESes do not display 
structural or sequence similarities and hence are grouped into a separate class of IRESes 
called cellular IRESes (R. J. Jackson et al., 2010). 
1.1.2.3 Mechanism of IRES-mediated translation 
The detailed mechanism of IRES-mediated translation remains unclear. As mentioned 
earlier, cellular IRESes do not have a structural similarity making it difficult to deduce a 
common mechanism of translation initiation for all mammalian IRESes (Hellen & 
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Sarnow, 2001; R. J. Jackson et al., 2010). Some of the cellular IRESes have been found to 
have a short nine-nucleotide Shine-Dalgarno-like sequence. This sequence is 
complementary to 18S rRNA and promotes ribosome loading onto the mRNA (Komar & 
Hatzoglou, 2011). Another possible mechanism is that the ribosomes land in the vicinity 
of the start codon and then scan down to recognize the first AUG sequence. This is called 
the ‘land and scan’ mechanism and is mostly observed in picornaviruses (Komar & 
Hatzoglou, 2011; Spriggs et al., 2009). In both these mechanisms, IRESes do not require 
an eIF4F complex or the entire repertoire of eIFs to recruit the ribosome. 
Chemical inhibitors and siRNA-mediated knockdown studies have demonstrated that 
cellular IRESes can initiate translation in the absence of eIF4E or full-length eIF4G, but 
do require eIF4A of the eIF4F complex (Komar & Hatzoglou, 2011; Tsai et al., 2014). 
The requirement for eIF4A can be attributed to eIF4A helicase activity required to 
unwind the secondary structure of the IRESes and allow scanning of mRNAs by the 
ribosome (Parsyan et al., 2011). eIF3 can also interact with the cellular IRESes in a 
conformation-specific manner to directly recruit the ribosome onto the 5’ UTR of the 
mRNA (Thakor et al., 2017). In stress conditions, IRES-mediated translation is not 
affected by eIF2α phosphorylation as IRES-mediated translation can utilize eIF5B as an 
alternative. eIF5B is an ortholog of prokaryotic initiation factor 2 and it delivers initiator 
tRNA into the P site of ribosome without the involvement of the ternary complex (Komar 
& Hatzoglou, 2011). In general, cellular IRESes harness only a subset of eIFs to recruit 
ribosomes onto the mRNA and tRNAi into the ribosome and initiate translation in a cap-
independent fashion.  
Besides eIFs, IRES-mediated translation initiation is affected by ITAFs such as poly-
pyrimidine tract binding protein (PTB), heterogeneous ribonucleoproteins (hnRNPs), 
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programmed cell death 4 protein (PDCD4), human antigen R (HuR) and La autoantigen 
(Hellen & Sarnow, 2001; Komar & Hatzoglou, 2011). Each ITAF has a characteristic role 
to playand can positively or negatively regulate translation. The possible modes of action 
of the ITAFs are i) modify mRNA structure on binding, ii) interact with ribosomes or 
other proteins, acting as molecular bridges and iii) function as molecular chaperones 
(Komar & Hatzoglou, 2011; Sharma, Bressler, Patel, Balasingam, & Thakor, 2016). 
These mechanisms can be elaborated with examples of human La, PDCD4, HuR, and 
MDM2 protein. Human La autoantigen acts as a molecular RNA chaperone, aiding in 
RNA folding to enhance IRES-mediated translation (Gao, Li, Zhu, & Jin, 2016; A. 
Kumar, Ray, & Das, 2013; Naeeni, Conte, & Bayfield, 2012). Similarly, HuR and MDM2 
proteins are positive regulators of translation. The binding of HuR increases the stability 
of mRNA and thus enhances translation (Zhang et al., 2009). The interaction of HuR and 
MDM2 with XIAP mRNA promotes its IRES activity, while another protein, 
heterogeneous ribonucleoprotein A1 (hnRNPA1), interacts with the XIAP mRNA to 
inhibit its IRES activity (Gu et al., 2009; Roy et al., 2014; Zhang et al., 2009). Like 
hnRNPA1, PDCD4 is a negative regulator of XIAP IRES-mediated translation (Suzuki et 
al., 2008). PDCD4 sequesters eIF4A by directly interacting with eIF4A. This results in 
the displacement of eIF4A and ultimately inhibition of translation (Pelletier, Graff, 
Ruggero, & Sonenberg, 2015; Suzuki et al., 2008). PDCD4 can also directly interact with 
mRNAs such as XIAP and Bcl-xL to inhibit the translation initiation complex formation 
(Biyanee, Singh, & Klempnauer, 2015; Liwak et al., 2012). Interaction of XIAP mRNA 
with PDCD4 or hnRNPA1 inhibits its translation, while the interaction of XIAP mRNA 
with HuR or MDM2 enhances its IRES-mediated translation. This suggests that IRES 
elements can interact with more than one ITAFs and the interaction with each one of 
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them can have a different outcome with respect to the IRES-mediated translation. It is 
possible that these ITAFs compete with each other to bind to their target IRESes. 
Therefore, the levels and/or activity of ITAFs can influence the cap-independent 
mechanism of translation.  
Non-canonical translation, although not dependent on all eIFs, is regulated by a subset of 
eIFs and ITAFs. Hence, the availability of eIFs and ITAFs determine the efficiency of 
IRES-mediated translation (Sharma et al., 2016). As IRES-mediated translation has an 
upper hand during stress, it can affect the types of proteins expressed in such condition 
and thus determine if the cell will survive or undergo apoptosis. 
1.2 Apoptosis 
Apoptosis is a systematic process of cell death that is also called programmed cell death. 
It is a process where a cell methodically undergoes death without any deleterious effect 
on the neighboring cells (Taylor, Cullen, & Martin, 2008). During this process, there are 
several morphological changes observed, such as shrinkage in cell size, tightly packed 
organelles, condensation of chromatin, blebbing of the plasma membrane and formation 
of apoptotic bodies. These apoptotic bodies are then engulfed by the immune cells 
without triggering an inflammatory response (Elmore, 2007). The apoptotic mechanisms 
are broadly classified into two pathways, the intrinsic apoptotic pathway, and extrinsic 
apoptotic pathway (Koff, Ramachandiran, & Bernal-Mizrachi, 2015). Additionally, there 
is the granzyme pathway that is induced by granzyme A or B. The intrinsic apoptotic 
pathway, extrinsic apoptotic pathway, and granzyme B pathway converge to activate 
caspases, while granzyme A functions via a caspase-independent mechanism (Elmore, 
2007). 
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There are two main classes of caspases, initiator and executioner caspases. Initiator 
caspases are at the receiving end of the stress signals while executioner caspases are 
downstream molecules that cleave cellular proteins influencing cell survival (McIlwain et 
al., 2013). The caspases are present as inactive procaspases that are activated by cleavage 
(Y. Shi, 2004). The initiator procaspases are inactive monomers and upon activation, they 
form dimers (Y. Shi, 2004). The formation of dimers stimulates autocatalytic cleavage of 
caspases to form active initiator caspases. On the other hand, executioner caspases are 
present as homodimers with reduced activity (Y. Shi, 2004). The activated initiator 
caspases cleave executioner procaspases. As a result of the cleavage, the conformation of 
the executioner caspase’s active sites are modified and the enzyme activity is enhanced 
(Y. Shi, 2004). 
1.2.1 Extrinsic apoptosis pathway 
In the extrinsic apoptotic pathway, death receptors, which are transmembrane proteins 
present on the plasma membrane, interact with their corresponding ligands to trigger 
apoptosis. Some of the examples of death receptors are Fas-R, TNFR1, TRAIL-R, CD95, 
Apo-3, and DR4/DR5; and their corresponding ligands are Fas-L, TNFα, TRAIL, CD95-
L, Apo-3L, and TRAIL respectively (Eggert et al., 2002; Elmore, 2007; Fulda & Debatin, 
2006; Ren et al., 2004). Interaction of TRAIL-R–TRAIL, CD95–CD95-L, and Fas-R–
Fas-L stimulates Fas-associated death domain (FADD) recruitment to the cytosolic 
domain of the receptor (Elmore, 2007). FADD is an adaptor protein and is essential to 
transfer the signals from the death receptor to the initiator caspases (Elmore, 2007; Fulda 
& Debatin, 2006). In the case of the TNFR1–TNFα interaction, in addition to FADD, 
TRADD and RIP are recruited to the cytosolic domain of TNFR1 (Figure 1.2) (Elmore, 
2007). Similar to FADD, TRADD and RIP are death receptor interacting proteins 
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essential to trigger apoptosis (Elmore, 2007). Upon FADD interaction with the death 
receptor, it forms a death-inducing signaling complex (DISC) along with procaspase 8/10 
and leads to oligomerization and autolytic cleavage of procaspase 8/10 to active caspase 
8/10 (Fulda & Debatin, 2006; J. Li & Yuan, 2008). Active caspases 8/10 then cleaves 
procaspases 3/7 to form active caspase 3/7, inducing apoptosis (Elmore, 2007). 
1.2.2 Intrinsic apoptosis pathway 
The intrinsic apoptosis pathway is also called the mitochondrial apoptosis pathway as it 
mainly depends on the release of pro-apoptotic molecules such as cytochrome c and 
second mitochondria-derived activator of caspase (smac) from the intermembrane space 
of mitochondria (Koff et al., 2015). Under sustained genotoxic stress conditions or 
nutrient deprivation, the mitochondrial membrane pores are opened (Elmore, 2007). As a 
result of the mitochondrial membrane depolarization, cytochrome c and smac proteins are 
released into the cytoplasm. The cytochrome c thus released forms an apoptosome 
complex by interacting with apoptotic protease activating factor 1 (Apaf1) and procaspase 
9. The apoptosome leads to cleavage of procaspase 9 and formation of active caspase 9. 
Activated caspase 9 then activates the downstream effector caspases 3/6/7, which induce 
apoptosis (Elmore, 2007). The smac released from the mitochondria into the cytoplasm 
can interact with the inhibitor of apoptosis proteins (IAPs) such as XIAP. Due to the smac 
interaction with the IAPs, IAPs are unavailable to interact with caspases and inhibit 
caspase function. Therefore, in presence of smac, caspases are available to induce 
apoptosis in cells (Figure 1.2) (Chai et al., 2000). In general, the mitochondrial membrane 
integrity plays a critical role in the intrinsic apoptosis pathway. The integrity of the 
mitochondrial membrane is modulated by the presence and absence of anti-apoptotic 
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proteins and pro-apoptotic proteins as well as receptor-mediated signaling (Elmore, 
2007). 
 
Figure 1.2: Schematic representation of the extrinsic and intrinsic pathways of apoptosis. 
i) Extrinsic pathway: In presence of extracellular inducers (ligands), TRADD and FADD 
are localized to the cytosolic domain of the death receptor. This leads to the formation of 
DISC and activation of procaspase 8/10. Activated caspase 8/10 triggers the caspase 
cascade; as a result, caspase3/7 is activated and induces apoptosis. ii) Intrinsic pathway: 
Stress-induced internal factors alter the membrane integrity of mitochondria that causes 
the release of cytochrome c and smac. Cytochrome c interacts with Apaf1 and procaspase 
9 to form the apoptosome. The formation of the apoptosome leads to the activation of 
caspase 9.This then triggers the caspase cascade resulting in active caspase 3/6/7 and 
execution of apoptosis. 
 
1.2.3 Anti-and pro-apoptotic proteins 
Proteins that inhibit apoptosis are called anti-apoptotic proteins. The Bcl-2 family of 
proteins and FADD-like IL-1β-converting enzyme-inhibitory protein (c-FLIP) are 
examples of anti-apoptotic proteins (Elmore, 2007; Safa, 2013). Overexpression of Bcl-
xL, which is a member of Bcl-2 family of proteins, inhibits the opening of mitochondrial 
membrane pore and prevents the release of cytochrome c. The inhibition of cytochrome c 
release inhibits apoptosome formation and downstream induction of apoptosis. Hence 
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Bcl-xL inhibits the intrinsic apoptotic pathway (Carthy et al., 2003). cFLIP has different 
splice variants such as long (c-FLIPL), short (c-FLIPS), and c-FLIPR (Ewald et al., 
2011). These variants of cFLIP are dysregulated in cancer (Gaidos, Panaitiu, Guo, 
Pellegrini, & Mierke, 2015; Safa & Pollok, 2011). cFLIP interacts with FADD and 
inhibits activation of caspases 8 and 10. As a result of caspase 8 and 10 inhibition, the 
extrinsic pathway of apoptosis is inhibited (Safa, 2013). 
In addition to the Bcl-2 family of proteins and c-FLIP, there is a sub-group of anti-
apoptotic proteins called IAPs. IAPs were initially discovered in baculoviruses (Owens, 
Gilmore, Streuli, & Foster, 2013). In humans, the IAPs are classified into 8 groups based 
on the conserved baculovirus IAP repeat (BIR) domain(s) and a zinc-binding domain 
(Oberoi-Khanuja, Murali, & Rajalingam, 2013). The protein must contain a BIR domain 
to be grouped under IAPs, but not all proteins with a BIR domain are inhibitors of 
apoptosis proteins (Schimmer, 2004). Besides the BIR domain/s and a zinc-binding 
domain, IAPs can also have an ubiquitin-associated domain (UBA), a really interesting 
new gene (RING) domain or a caspase activation recruitment (CARD) domain 
(Schimmer, 2004; Silke & Meier, 2013). Furthermore, IAPs are characterized by their 
ability to bind with caspases and to inhibit their activity (Schimmer, 2004). Due to this 
function of inhibiting caspase activity, IAPs are regarded as crucial factors in deciding 
cell fate during apoptosis. Other than apoptosis, IAP-IAP complexes facilitate cell 
differentiation, inflammation, cell migration and oncogenesis (Oberoi-Khanuja et al., 
2013). cIAP1, cIAP2, survivin, XIAP, BRUCE/Apollon, and Livin are some of the well-
characterized IAPs (Owens et al., 2013; Silke & Meier, 2013). cIAP1 and cIAP2 interact 
with TNF receptor-associated factors 1 and 2 and inhibit the extrinsic pathway of 
apoptosis (Guicciardi et al., 2011; Labbe, McIntire, Doiron, Leblanc, & Saleh, 2011). 
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Livin interacts with active caspase 3/7 and inhibits both the extrinsic and the intrinsic 
pathways of apoptosis (Kasof & Gomes, 2001). XIAP belongs to the BIRC4 class of 
IAPs. XIAP consists of 3 BIR domains and a RING domain. XIAP interacts with 
caspases 3, 7, and 9 via the BIR domain and inhibits caspase activity. The RING domain 
is important for ubiquitination of its substrate such as caspase 7 as well as 
autoubiquitination (Creagh, Murphy, Duriez, Duckett, & Martin, 2004; Deveraux & 
Reed, 1999; Oberoi-Khanuja et al., 2013). Ubiquitination of the substrate, promotes 
proteasomal degradation of the substrate. Autoubiquitination leads to proteasomal 
degradation of XIAP and hence the level of XIAP protein can be regulated by 
autoubiquitination (Galban & Duckett, 2010). To summarize, IAPs interact with initiator 
and executioner caspases and inhibit caspase-dependent apoptosis by occluding caspases 
or by ubiquitinating them.  
In contrast to anti-apoptotic proteins, pro-apoptotic proteins are positive regulators of 
apoptosis. PDCD4 and a subset of Bcl-2 family proteins (BID, Bax, and Bak) are 
examples of pro-apoptotic proteins (Kluck et al., 1999; Tsujimoto, 1998; Wigington et al., 
2015; Zhen et al., 2013). BID and Bax interact with the outer membrane of mitochondria, 
open the mitochondrial membrane pore and facilitate the release of cytochrome c (Kluck 
et al., 1999). There are also reports suggesting internalization of BID and Bax from the 
cytoplasm into mitochondria to interact with the adenine nucleotide translocator present 
on inner mitochondrial membrane to release cytochrome c (Kluck et al., 1999). Upon 
TNFα-mediated activation of apoptosis, cytosolic Bid is cleaved to truncated BID (tBID). 
tBID induces cytochrome c release by inducing the oligomerization of Bax or Bak 
(Grinberg et al., 2002; Sutton et al., 2000). Besides TNFα, other receptor-mediated 
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activation of apoptosis and granzyme B pathway can trigger the formation of tBID to 
promote the release of cytochrome c (H. Li, Zhu, Xu, & Yuan, 1998). In general, the 
activity and levels of anti-apoptotic and pro-apoptotic proteins regulate the mechanism of 
cell survival. The synthesis and/or the activity of anti-apoptotic and pro-apoptotic proteins 
can be regulated by pathways such as mTOR pathway. 
1.3 mTOR pathway 
mTOR is a serine/threonine kinase that is a part of the phosphatidylinositol 3-kinase 
(PI3K) pathway. mTOR interacts with several other proteins to form two types of 
complexes called mTOR complex 1 (mTORC1) and mTOR complex 2 (mTORC2) 
(Zarogoulidis et al., 2014). mTORC1 and mTORC2 are extensively studied for their role 
in cell growth as they converge external signals such as growth factors, nutrients, and 
oxygen towards catabolic processes in cells (Laplante & Sabatini, 2012). mTORC2 plays 
a role in cell survival and cytoskeletal organization while mTORC1 influences protein 
translation, energy metabolism, lipid biosynthesis and autophagy (Laplante & Sabatini, 
2012). Due to the relevance of mTORC1 in the regulation of protein translation, I have 
focused on mTORC1 and not mTORC2 in this section. 
mTORC1 is composed of six different proteins namely mTOR, a regulatory associated 
protein of mTOR (raptor), proline-rich Akt substrate 40 kDa (pras40), DEP domain 
containing mTOR-interacting protein (deptor), mammalian lethal with sec-13 (mLST8), 
and the Tti1/Tel2 complex (Laplante & Sabatini, 2012; Zarogoulidis et al., 2014). Each of 
these six proteins has a distinct function as a part of the complex and mTOR is the core of 
the complex. Deptor and pras40 inhibit the function of mTOR. Raptor and Tti1/Tel2 
complex act as scaffold proteins and influence the substrate binding (Laplante & Sabatini, 
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2012). mLST8 is essential for the kinase activity of mTOR (Kakumoto, Ikeda, Okada, 
Morii, & Oneyama, 2015). Functionally, mTORC1 is regulated by upstream positive and 
negative regulators. Events leading to the phosphorylation of mTORC1 activate the 
complex, and conversely, dephosphorylation events inhibit the activity of mTORC1. 
mTORC1 is negatively regulated by phosphatases like PTEN and positively by kinases 
like AKT. AKT phosphorylates pras40 and TCS2 and relieves mTORC1 from the 
inhibitory effect of these proteins (Hay & Sonenberg, 2004; Porta, Paglino, & Mosca, 
2014; M. S. Song, Salmena, & Pandolfi, 2012). TSC1 and 2 are present upstream to 
mTORC1. Many of the external or internal signals phosphorylate or dephosphorylate 
TSC1 and TSC2 to regulate mTORC1 activity (Laplante & Sabatini, 2012). Upon 
mTORC1 phosphorylation, it hyperphosphorylates 4E-BPs, p70 ribosomal proteinS6 
kinase 1 (S6K1) and S6K2 and maf1 (Laplante & Sabatini, 2013). Phosphorylation of 4E-
BP and S6K1 and 2 directly enhance translation, while phosphorylation of maf1 promotes 
transcription of tRNAs and rRNA genes required for translation (Laplante & Sabatini, 
2012). Maf1 is a repressor of RNA polymerase III. Phosphorylation of maf1 by mTORC1 
relives RNA polymerase III from maf1 repression and promotes ribosome biogenesis and 
tRNA synthesis (Laplante & Sabatini, 2012). In particular, S6K1 and 2 have several 
downstream targets that can influence apoptosis by regulating translation. 
1.3.1 S6K 
S6K1 and 2 are serine-threonine kinases (Tavares et al., 2015). S6K1 and S6K2 share an 
83% homology in the kinase domain and hence S6K2 was considered as a redundant 
protein in mammals. Extensive research to study the differences between S6K1 and S6K2 
indicated that they do have similarities as well as distinct roles to play in cells (Karlsson 
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et al., 2015; Pardo & Seckl, 2013; Tavares et al., 2015). S6K1 and 2 function by 
phosphorylating and modifying the function of the substrate such as PDCD4 and eIF3 
(Liwak et al., 2013; Martineau et al., 2014). S6K1 and 2 contain nuclear localization 
signals and can shuttle between the cytoplasm and nucleus (Pardo & Seckl, 2013). 
p85S6K1 and p70S6K1 are the two isoforms of S6K1. p85S6K1 includes an additional 23 
amino acids in the N-terminus in comparison to p70S6K1. This additional sequence of 
amino acids is considered to contain the nuclear localization signal, making p85S6K1 a 
nuclear protein and p70S6K1 a cytoplasmic protein (Kim, Akcakanat, Singh, Sharma, & 
Meric-Bernstam, 2009). S6K1 targets the nuclear pool of ribosomal protein S6 and 
transcription factor cAMP-response element modulator in the nucleus, and to modulate 
the translational and transcriptional efficiency of cells (Edelmann, Kuhne, Petritsch, & 
Ballou, 1996). 
Like S6K1, S6K2 has two isoforms called p56S6K2 and p54S6K2. p56S6K2 contains 
two nuclear localization signals and has been found to be localized in the nucleus (Pardo 
& Seckl, 2013). The second isoform, p54S6K2, is a shorter isoform and is found to 
shuttle between the nucleus and the cytoplasm (Pardo & Seckl, 2013). The translocation 
of the S6K2 protein is observed in the presence of growth factors (Pardo & Seckl, 2013). 
In presence of nutrition or growth signals, S6K1 and 2 phosphorylate S6 protein and 
enhance canonical and non-canonical translation initiation. Besides S6, S6K1 and 2 can 
also phosphorylate PDCD4 and eIF3 subunits to regulate translation initiation as 
mentioned below in section 1.3.2 (Martineau et al., 2014; Pardo & Seckl, 2013). 
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1.3.2 Regulation of protein translation by S6K 
In the presence of mitogens, mTORC1 is activated and this, in turn, activates p70S6K1 
(Fang, Meng, Vogt, Zhang, & Jiang, 2006). Activated p70S6K1 phosphorylates eIF4B, 
eIF3, eukaryotic elongation factor 2 kinase and PDCD4 to enhance translation (Dennis, 
Jefferson, & Kimball, 2012; Martineau et al., 2014). With the focal point being translation 
initiation, I have only explained the S6K-mediated regulation of eIF4B, eIF3 and PDCD4 
and not elongation factor 2 kinase. eIF4B is a eukaryotic initiation factor involved in the 
cap-dependent translation (Lindqvist, Imataka, & Pelletier, 2008). eIF4B acts as a co-
factor important for the helicase activity of eIF4A and increases mRNA translation 
(Shahbazian et al., 2006). eIF4B consists of two RNA binding domains and a protein 
binding domain. The RNA binding domain is essential for mRNA and rRNA binding, and 
thus forms a bridge between the mRNA and ribosome (van Gorp et al., 2009). The protein 
binding domain interacts with eIF3, aiding initiation complex formation (van Gorp et al., 
2009). In the presence of serum or mitogens, eIF4B is phosphorylated on Serine-422 by 
p70S6K1 (Kuang, Fu, Liang, Myoung, & Zhu, 2011; Mendoza, Er, & Blenis, 2011). 
FLAG-immunoprecipitation assays have demonstrated that phosphorylation of eIF4B 
augments the eIF4B and eIF3A subunit interaction (Shahbazian et al., 2006). Mutations 
impairing the phosphorylation of eIF4B have a negative effect on translation initiation 
(van Gorp et al., 2009). Thus, p70S6K1-mediated phosphorylation of eIF4B has an effect 
on general cap-dependent translation and cell proliferation. The effect on cell 
proliferation could be due to the requirement for eIF4B for the mRNA translation of pro-
survival mRNAs such as Bcl-2 and XIAP (Shahbazian et al., 2006). 
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eIF3 is an 800 kDa multi-subunit complex consisting of 13 subunits. The subunits are 
non-identical and denoted by letters A to M. Each subunit has a designated role in 
translation initiation (Hinnebusch, 2006). eIF3A, eIF3C, eIF3E, eIF3F, eIF3H, eIF3K, 
eIF3L and eIF3M form the structural core in human eIF3 (Cate, 2017). eIF3A, eIF3B, 
eIF3C and eIF3J play roles in 40S binding; eIF3A, eIF3B and eIF3C in mRNA 
recruitment; eIF3B is critical for mRNA scanning and eIF3C for AUG recognition. 
eIF3A, eIF3B, and eIF3C help in the recruitment of ternary complex to the 40S subunit to 
form the 43S pre-initiation complex (Hinnebusch, 2006). Many of the eIF3 subunits 
undergo post-translational modifications that promote their interactions with other 
proteins. eIF3 subunits contain multiple phosphorylation sites that are regulated by 
mTOR-dependent and mTOR-independent signaling pathways (Martineau et al., 2014; 
Miyamoto, Patel, & Hershey, 2005). Inactive S6K1 remains associated with the eIF3 
complex. mTORC1 activation phosphorylates S6K1 and abrogates the eIF3-S6K1 
interaction (Ma & Blenis, 2009). Activated S6K1 phosphorylates multiple proteins 
including eIF3 subunits. S6K1 directly interacts with eIF3F and phosphorylates eIF3G to 
regulate translation (Martineau et al., 2014). Phosphorylation of eIF3G by S6K1 promotes 
the eIF3-polyadenylate-binding protein-interacting protein 1 (PAIP1) interaction 
(Martineau et al., 2014). Under amino acid starvation condition or treatment with mTOR 
inhibitors, the interaction between eIF3 and PAIP1 is interrupted (Martineau et al., 2014). 
This suggests the requirement for S6K1 for the interaction. The interaction between eIF3 
and PAIP1 promotes mRNA circularization and, in turn, enhances translation (Martineau 
et al., 2014). Immunoprecipitation assays conducted using human embryonic kidney 
(HEK) cells have shown that S6K1 interacts with eIF3B, eIF3C, eIF3E and eIF3F, and 
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mTOR with eIF3C to regulate translation (Holz, Ballif, Gygi, & Blenis, 2005; Martineau 
et al., 2014). 
S6K1 phosphorylates PDCD4 on the serine-67 residue, this phosphorylation triggers 
additional phosphorylation on the serine-71 and serine-76 residues of the protein 
(Dorrello et al., 2006; Magnuson, Ekim, & Fingar, 2012). Phosphorylated PDCD4 was 
co-immunoprecipitated with SCFβTRCP1 and SCFβTRCP2, suggesting that PDCD4 could be 
ubiquitinated by the ubiquitin ligase SCFβTRC. In addition, PDCD4 contains a SCFβTRC 
binding domain, further supporting the possibility of PDCD4 ubiquitination by SCFβTRC 
(Dorrello et al., 2006). The interaction between PDCD4 and the ubiquitin ligase SCFβTRC 
is lost when similar immunoprecipitation assays were conducted with serine-71 and 
serine-76 mutants. Hence, it is important for all three phosphorylation reactions to occur 
on PDCD4 for the protein to be recognized by SCFβTRC and degraded (Dorrello et al., 
2006; Magnuson et al., 2012). Downregulation of PDCD4 increases translation of a 
subset of mRNAs including XIAP and Bcl-xL mRNAs. As a result, the increase in 
translation of XIAP and Bcl-xL promotes cell survival (N. Kumar, Wethkamp, Waters, 
Carr, & Klempnauer, 2013; Liwak et al., 2012; Schmid et al., 2008). 
Like S6K1, S6K2 phosphorylate S6, PDCD4, and eIF3 to have a similar effect on 
translation (Liwak et al., 2012; Martineau et al., 2014; Pardo & Seckl, 2013). S6K2 
mostly affects the cap-independent translation of Bcl-xL, XIAP, and a subset of mRNAs 
consisting of an IRES element. S6K2 does not affect the cap-dependent translation of 
housekeeping genes. XIAP mRNA expression is also positively affected by the 
phosphorylation of PDCD4 mediated by S6K2 (Liwak et al., 2012; Pardo & Seckl, 2013). 
Hence, S6K1 and 2 mediated post-translational regulation of PDCD4 and eIF3 can 
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modulate both cap-dependent and cap-independent translation and therefore affect cell 
survival. 
1.4 PDCD4 
PDCD4 is found to have a reduced expression in many cancer types such as lung cancer, 
melanoma, and glioblastoma (Y. Chen et al., 2003; Liwak et al., 2013; Vikhreva & 
Korobko, 2014). The decrease in PDCD4 expression is due to epigenetic silencing, post-
transcriptional and post-translational regulation (Liwak et al., 2013). Post-
transcriptionally, miR-21 and miR-499 target the 3’ UTR of PDCD4 mRNA and silence 
gene expression. The levels of miR-21 and miR-499 are inversely proportional to PDCD4 
protein levels, emphasizing the antagonistic effect of these miRNAs on PDCD4 in cancer 
cells (Asangani et al., 2008; Zhang et al., 2016). As mentioned earlier, PDCD4 is post-
translationally modified by S6K1 and 2. The phosphorylated form of PDCD4 protein is 
susceptible to ubiquitin-mediated degradation (Dorrello et al., 2006; Galan et al., 2014; 
Liwak et al., 2012). The loss of PDCD4 is correlated with increased cell proliferation and 
resistance to apoptosis (Vikhreva & Korobko, 2014). Due to its role in the enhancement 
of apoptosis and inhibition of cancer cell proliferation, PDCD4 is commonly known as a 
tumor suppressor protein (Z. Chen et al., 2015; Zhen et al., 2016). 
PDCD4 contains a nuclear localization signal and can shuttle between the nucleus and the 
cytoplasm (Bohm et al., 2003). In the nucleus, it affects the function of transcription 
factors such as twist1 and c-Jun, and in the cytoplasm, it modulates the translation 
efficiency of specific mRNAs (Jo, Kim, Clocchiatti, & Dotto, 2016; N. Kumar et al., 
2013; Liwak et al., 2012). Other than the nuclear localization signal, PDCD4 contains two 
MA3 binding domains and an RNA binding domain (Chang et al., 2009). It utilizes both 
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the MA3 binding domains to interact with eIF4A and to inhibit its helicase activity or to 
compete with eIF4G and prevent eIF4F complex formation. By inhibiting eIF4A helicase 
activity and eIF4F complex formation, PDCD4 abrogates cap-dependent translation 
(Chang et al., 2009). In addition to inhibiting cap-dependent translation, PDCD4 directly 
interacts with XIAP and the Bcl-xL IRESes via the RNA binding domain and inhibits 48S 
initiation complex formation (Liwak et al., 2012). As a result, during apoptosis, PDCD4 
can potentially inhibit global as well as transcript-specific translation. In many cancers, 
such as glioblastoma and ovarian cancer, the PDCD4 expression is downregulated and as 
a consequence of this, the levels of anti-apoptotic proteins are increased, resulting in 
higher chemoresistance and cell migration (Liwak et al., 2013; Wei, Liu, Chan, & Ngan, 
2012). 
1.5 Role of eIF3 in translation and apoptosis 
The expression of all 13 subunits in the eIF3 complex may not be dysregulated at the 
same time. Nevertheless, even variation in any one of these eIF3 subunits can have 
implications in cancer, apoptosis and cell growth (Sharma et al., 2016). eIF3A is 
upregulated in breast cancer and lung cancer (Dong & Zhang, 2006; Hershey, 2015). 
This, in turn, upregulates ribonucleotide reductase M2 during S phase of the cell cycle to 
promote DNA synthesis and malignancy (Sharma et al., 2016). Another subunit, eIF3C is 
upregulated in tumor cells to facilitate cell proliferation (N. Song, Wang, Gu, Chen, & 
Shi, 2013). This activity of eIF3C can be restricted by direct interaction with a tumor 
suppressor protein schwannomin (Scoles, Yong, Qin, Wawrowsky, & Pulst, 2006). 
Similarly to eIF3A and eIF3C subunits, eIF3D is upregulated in gastric and mesothelial 
tissue cancer. Knockdown of the eIF3D subunit in human colon cancer cells decreased 
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cell proliferation and colony formation, promoted activity of pro-apoptotic proteins such 
as Bad by phosphorylation, and cleaved PARP (Spilka, Ernst, Mehta, & Haybaeck, 2013; 
Yu, Zheng, & Chai, 2014). Besides, eIF3A, eIF3C and eIF3D, eIF3E is found to be 
dysregulated in many cancer types (Grzmil et al., 2010; Sesen et al., 2014). Partial 
silencing of eIF3E specifically inhibited the expression of a subset of mRNAs related to 
tumorigenesis but not a global translation (Grzmil et al., 2010). A reduction in eIF3E 
promoted epithelial-to-mesenchymal transition by stabilizing and increasing expression of 
epithelial-to-mesenchymal transition regulators such as Snail1 and Zeb2 (Gillis & Lewis, 
2013). Also, a decrease in eIF3E further decreased Bcl-xL (anti-apoptotic protein) and 
urokinase-type plasminogen activator (activator of metastasis) (Grzmil et al., 2010; 
Sharma et al., 2016). Unlike other eIF3 subunits, eIF3F has been mostly shown to 
function as a tumor suppressor protein (Sharma et al., 2016). eIF3F stabilizes p53 (tumor 
suppressor protein), activates Bax, promotes rRNA degradation and inhibits tumor growth 
in mice (J. Y. Lee, Kim, Rho, & Lee, 2016). eIF3F sequesters hnRNP K. As a result, 
rRNA molecules are no longer protected by hnRNPK. The unprotected rRNAs become 
susceptible to nuclease degradation inhibiting protein synthesis (Wen et al., 2012). eIF3F 
is shown to affect both cap-dependent and cap-independent translation using luciferase 
reporter constructs in immortalized cell lines (Wen et al., 2012). Collectively, these data 
suggest that eIF3 plays a role in translating the mRNAs that influence apoptosis. 
To summarize, eIF3 being a large multi-protein complex (Hershey, 2015), it is not clear if 
the subunits play a role independent of one another. The function of these subunits can be 
influenced by one another or other cellular proteins. Also, the interaction of eIF3 with one 
another and with other cellular protein may affect translation (Hershey, 2015; Martineau 
et al., 2014; Thakor et al., 2017). 
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1.6 Objectives 
PDCD4 has been demonstrated to function as a transition inhibitor (Liwak et al., 2013; 
Liwak et al., 2012). As mentioned earlier, PDCD4 interacts with eIF4A and inhibits cap-
dependent translation (Liwak et al., 2012). Besides the negative effect on cap-dependent 
translation, PDCD4 directly interacts with XIAP and Bcl-xL mRNAs to downregulate 
their IRES-mediated translation (Liwak et al., 2012). Besides these, our group has 
recently shown that the eIF3 complex directly interacts with XIAP mRNA to enhance its 
translation (Thakor et al., 2017). These observations suggest that PDCD4 binding 
negatively regulates XIAP translation, while eIF3 binding positively regulates the 
expression of the XIAP mRNA (Figure 1.3). Interestingly, both PDCD4 and eIF3 are 
regulated by a common mTOR/S6Ks pathway (Figure 1.3). S6K1 and 2, downstream 
kinases in the mTOR pathway, are known to phosphorylate PDCD4 leading to its 
degradation (Figure 1.3). S6K1 and 2 also phosphorylate eIF3 to enhance its role in 
translation (Figure 1.3). Therefore, I hypothesize that PDCD4 interacts with eIF3 to 
inhibit translation initiation, and that the interaction of eIF3 and PDCD4 is regulated via 
S6K1 and/or 2. To this end, I focused my study on the following objectives. 
Objective i) To investigate if PDCD4 interacts with eIF3. 
Objective ii) To demonstrate if the inhibition of S6K1 and 2 activation affects the 
interaction between PDCD4 and eIF3. 
Objective iii) To study the effect of eIF3F and PDCD4 on cap-dependent translation in 
glioblastoma cell line (U343). 
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Figure 1.3: Schematic representation of S6K mediated translation regulation. mTOR 
activates S6K1 and 2. Activated S6K1 and 2 inhibits PDCD4 and enhances the function 
of the eIF3 complex. PDCD4 inhibits XIAP translation, while, eIF3 enhances XIAP 
translation. 
 
eIF3 is a common factor required for both canonical and IRES-mediated translation 
initiation. Therefore, the interaction between PDCD4 and eIF3 can have an impact on 
cap-dependent and cap-independent translation. The results of the project will provide us 
further insights into the PDCD4-mediated regulation of translation during apoptosis.  
mTOR
S6K
PDCD4 eIF3
XIAP IRES-mediated 
translation
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Chapter 2 
Materials and methods 
2.1 Cell lines and constructs 
Human glioblastoma cell line U343, S6K double knockout mouse embryonic fibroblast 
cells (MEFs) and wild-type MEFs were used for the in cellulo assays. Both MEFs lines 
were obtained from Dr. Tommy Alain, CHEO Research Institute, University of Ottawa. 
The plasmids used for expression of proteins and reporter constructs to monitor cap-
dependent and cap-independent translation are tabulated below. 
Sl. 
No 
Construct Application Source Reference 
1 2G-T.f 
Bacterial expression of GST-
eIF3F 
Dr. Jamie H. D. 
Cate, University of 
California, Berkeley. 
(Sun et al., 
2011) 
2 
His-
PDCD4 
Bacterial expression of His-
PDCD4 
Dr. Martin Holcik, 
CHEO Research 
Institute, University 
of Ottawa 
(Liwak et 
al., 2012) 
3 
pcDNA3-
PDCD4-
FLAG 
Mammalian expression of 
FLAG-PDCD4 
4 
GST-
PDCD4 
Bacterial expression of GST-
PDCD4 
5 
pcDNA3-
FLAG 
Mammalian expression of 
FLAG-tag 
6 
pRL-
CMV 
Monitor cap-dependent 
translation in mammalian cells 
Promega - 
7 
pGEX-
4T1-GST 
Bacterial expression of GST 
protein 
Dr. Hans-Joachim 
Wieden, University 
of Lethbridge 
- 
 
Table 2.1: List of constructs, application of the constructs and their source.  
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2.2 Transfection and transformation 
All mammalian cell lines were maintained in the Dulbecco's Modified Eagle's Medium 
(DMEM) (Hyclone) supplemented with 10% v/v fetal bovine serum (FBS), L-glutamine 
and penicillin/streptomycin. Before transfection, cells were trypsinized and counted using 
the trypan blue staining. 3X106 cells were then seeded into a 100-mm tissue culture plate 
for transfection. 48 hours after seeding the cells, the plate was used for transfection. 
Mammalian cells were transiently transfected with the pcDNA3-PDCD4-FLAG and 
pcDNA3-FLAG plasmid for the expression of FLAG-PDCD4 and FLAG peptide 
respectively using LipofectamineTM 2000 transfection reagent (ThermoFischer Scientific). 
The DNA, transfection reagent, and reduced-serum opti-MEM media were mixed in 
proportions as per the manufacturer’s protocol and incubated at ambient temperature for 
20 minutes. The transfection mix was then added into the 100-mm tissue culture dish 
containing a monolayer of mammalian cells. The cells were incubated in the 37 0C CO2 
incubator for 48 hours before lysis.  
In case of siRNA and pRL-CMV transfection, the cells from a 100-mm tissue culture 
plate were trypsinized. The number of cells present in the suspension was counted by the 
trypan blue staining. 3X105 cells from that cell suspension were then seeded into three 
wells of a 6-well plate. After seeding the cells, siPDCD4 (Dharmacon) and sieIF3F 
(Dharmacon) were transfected using Lipofectamine® RNAiMAX transfection reagent 
from Thermo FischerScientific. Transfection mix containing Lipofectamine® RNAiMAX 
transfection reagent, siRNA and opti-MEM media (Thermo FischerScientific) were 
mixed and incubated for 20 minutes at ambient temperature. The transfection mix was 
added into the tissue culture dish containing a mammalian cell suspension. The plate was 
incubated in the 37 0C CO2 incubator for 24 hours for the monolayer formation and 
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depletion of the target mRNA. Post 24 hours, cells were transfected with the pRL-CMV 
construct. The pRL-CMV plasmid, LipofectamineTM 2000 transfection reagent, and 
reduced-serum opti-MEM media were mixed in proportions as per the manufacturer’s 
protocol and incubated at an ambient temperature for 20 minutes. During the incubation 
period, cells in the 6-well plate were washed with opti-MEM and 750µL of opti-MEM 
was added into each well. After the incubation of the transfection mix, it was added to the 
opti-MEM media in the 6-well plate. The cells were incubated with the transfection mix 
for 4 hours and then the opti-MEM media was replaced with DMEM containing 10% v/v 
FBS. The cells were incubated for 24 hours before lysis. 
Escherichia coli (E. coli) strains such as DH5α (NEB), BL21 DE3 (NEB) and BL21 
ROSETTA 2 (DE3) PLYSS (Millipore Sigma) were used for transformation. DH5α was 
used for plasmid preparation, BL21 DE3 for PDCD4 and GST protein purification, and 
BL21 ROSETTA 2 (DE3) PLYSS for eIF3 subunit protein purification. 50ng of plasmid 
DNA was added to the 25µL aliquot of E.coli competent cells in a 1.5mL tube. Cells were 
incubated on ice for 45 minutes followed by a heat shock at 42 0C for 60 seconds. The 
cells were then placed on ice for 5 minutes and transferred into a culture tube containing 
1mL LB broth. The culture tube was incubated in a 37 0C shaker for 30 minutes. The cells 
were then plated onto LB agar plates containing 100µg/mL final concentration of 
ampicillin and incubated overnight in a 37 0C incubator. 
2.3 Plasmid purification 
A single colony of E. coli containing pcDNA3-FLAG plasmid or pcDNA3-PDCD4-
FLAG plasmid from the LB agar was inoculated into a 3mL LB broth containing 
100µg/mL final concentration of ampicillin. The 3mL starter culture was incubated at 
37 0C shaker for 10 hours. 1mL from the starter culture was then inoculated into 200mL 
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LB broth containing 100µg/mL final concentration of ampicillin. The 200mL culture was 
then incubated overnight at 37 0C with a constant shaking at 150 rpm. The overnight 
culture was used for the purification of the plasmid with the Qiagen plasmid maxiprep kit. 
The cells were harvested by centrifuging the 200mL culture at 6,000g for 15 minutes and 
the plasmid was purified as per the manufacturer’s recommendation. The quality of the 
plasmid purified was analyzed on a 0.8% w/v agarose gel and quantified using the 
BioDrop spectrophotometer. 
2.4 Optimization of protein purification 
Various concentrations of IPTG were tested to optimize the induction of His-PDCD4, 
GST-eIF3F and GST proteins. To begin with, 3mL of the E. coli culture was grown to 0.6 
OD and induced with a 0.1mM, 0.5mM, and 1mM final concentration of IPTG. The tubes 
were then incubated for 3 hours at 37 0C post-induction. 1mL of the culture was 
centrifuged and the pellet was re-suspended in 0.25mL of the lysis buffer used for 
recombinant protein purification. To the 0.25mL of the cell suspension, 60µL of 5X 
concentration SDS loading dye was added and incubated for 5 minutes at 98 0C. The 
samples were centrifuged at 10,000g for 5 minutes.  20µL of the supernatant was 
analyzed on a 10% w/v SDS-PAGE followed by Coomassie staining to detect the 
proteins. 
To confirm His-PDCD4 and GST-eIF3F expression Western blot assay was performed. 
The samples were processed like in the case of Coomassie-stained gels but were diluted 
by 10-fold and 100-fold before loading in to the 10% w/v SDS-PAGE. The proteins were 
transferred onto a nitrocellulose membrane by Western blotting. The nitrocellulose 
membrane was then stained using Ponceau Stain to ensure uniform protein loading in all 
34 
 
the lanes. The membrane was then de-stained by washing for 10 minutes with 1X 
concentration PBS solution. The membrane was then blocked with 10% w/v milk for 1 
hour at ambient temperature and then probed with primary antibody (anti-eIF3F/anti-
PDCD4) overnight at 4 0C. After the overnight incubation, the blot was washed for 10 
minutes with 1X PBST (twice) and 10 minutes with 1X PBS (once) to remove the 
unbound primary antibody. The blot was then probed with anti-rabbit secondary antibody 
and visualized using an Amersham Imager 600. 
2.5 Recombinant protein purification 
A single colony of E. coli containing His-PDCD4, GST-eIF3F, or GST bacterial 
expression construct was inoculated into a 3mL LB broth (containing 100µg/mL final 
concentration of ampicillin) and incubated overnight at 37 0C. 1mL of the starter culture 
was inoculated into 200mL of LB broth containing ampicillin and incubated at 37 0C with 
constant shaking at 150 rpm. The culture was induced with 0.5mM IPTG at 0.6 OD.  The 
culture was incubated for 3 hours after induction and then pelleted by centrifuging at 
6,000g for 30 minutes. The pellet was suspended in 20mL of lysis buffer (50mM Tris-
HCl pH 8, 1M NaCl, 5% v/v glycerol, 0.5mM PMSF, and 1mM β-mercaptoethanol) and 
then lysed using a French press. The lysate was centrifuged at 16,000g for 30 minutes and 
the supernatant was added into a 50mL tube containing 500µL of equilibrated 
Glutathione Sepharose 4 Fast Flow affinity medium (GE) or Ni-NTA agarose (Qiagen). 
The lysate was incubated with affinity matrix for 1 hour at 4 0C. The lysate was 
centrifuged at 1,000g for 2 minutes and the supernatant was discarded. The matrix was 
washed with 20mL of lysis buffer three times. In case of His-PDCD4 protein purification, 
40mM of imidazole was added to the lysis buffer during the wash step. GST and GST-
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tagged protein were eluted using 10mM glutathione in the lysis buffer. His-PDCD4 was 
eluted with 500mM imidazole in the lysis buffer. 20µL of each of the eluates were 
separated using SDS-PAGE and visualized by Coomassie staining. The eluates were 
pooled based on the purity and concentrated for in vitro assays. 
2.6 Western blot assay 
Cells were harvested in RIPA (50mM Tris-HCl pH 7.4, 1mM EDTA, 150mM NaCl, 1% 
v/v NP 40, 0.5% w/v deoxycholic acid, 0.05% w/v SDS, protease inhibitors and 
phosphatase inhibitors). The lysate was centrifuged at 10,000g for 10 minutes to remove 
the cell debris. The protein concentration of the supernatant was quantified by the 
Bradford assay, using the 1X Bradford assay reagent from BioRad. 5µL of the cell lysate 
was added into 500µL of the 1X Bradford assay reagent and incubated for 5 minutes at an 
ambient temperature. Likewise, 5µL of the protein standards ranging from 2mg/mL to 
0.125mg/mL bovine serum albumin solution was added into 500µL of the 1X Bradford 
assay reagent and incubated for 5 minutes at an ambient temperature. The absorbance of 
the samples was measured at 595 nm using the BioTek® luminescence plate reader. The 
protein concentration of the cell lysate was deduced based on the absorbance values 
obtained for the protein standards. After protein quantification, 10ng of each lysate was 
analyzed on SDS-PAGE. The proteins were transferred onto a nitrocellulose membrane, 
incubated with 10% w/v milk in 1X PBST (137mM NaCl, 2.7mM KCl, 10mM Na2HPO4, 
1.8mM KH2PO4, and 1% tween 20) for 1 hour followed by incubation with primary 
antibody overnight at 4 0C. The blots were then incubated with secondary antibody for 
one hour and visualized using an Amersham Imager 600. The primary and secondary 
antibodies were commercially available and the dilutions used were as per the 
manufacturer’s recommendation. The list of antibodies used are, PDCD4 (Rockland), 
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eIF3 subunits (Abcam), S6 (CST), pS6 (CST), actin (Bio-Rad), secondary rabbit 
(Abcam), secondary mouse (CST) and conformation-specific secondary anti-rabbit 
(CST). 
2.7 FLAG-immunoprecipitation 
U343 cells were transfected with pcDNA3-FLAG or pcDNA3-PDCD4-FLAG plasmids. 
Post 48 hours of transfection the cells were treated with 3.4% v/v formaldehyde for 10 
minutes followed by 10 minutes incubation with 0.02mM glycine to remove the excess 
formaldehyde. The cells were washed with PBS and then the cells were lysed in 1.1mL of 
RIPA buffer. The lysate was centrifuged at 10,000g for 10 minutes and the supernatant 
was transferred into a 1.5mL tube. 1mL of the lysate was added into a 1.5mL tube 
containing 40µL of equilibrated ANTI-FLAG® M2 Affinity Gel (Sigma). The lysate was 
incubated with the affinity gel in the cyclomixer for 4 hours at 4 0C. After incubation, the 
beads were isolated by centrifuging at 5,000g for 30 seconds. The matrix was washed 
with 500µL of 1X PBS four times. The proteins were eluted by addition of 40µL of 2X 
concentration Laemmli sample buffer (Bio-Rad) and heating for 10 minutes at 98 0C. The 
samples were analyzed using the Western blotting technique. 1% of the total cell lysate 
used for IP was loaded in the SDS-PAGE along with co-IP samples as input control. 
2.8 FLAG-IP to detect RNA-independent protein-protein interaction 
Two sets of U343 cells containing 100-mm tissue culture dish were transfected with the 
pcDNA3-FLAG or pcDNA3-PDCD4-FLAG plasmids. Each of the two sets had a 100-
mm plate containing U343 transfected with the pcDNA3-FLAG and a 100-mm plate 
containing U343 transfected with the pcDNA3-PDCD4-FLAG plasmid. After 48 hours of 
transfection, set 1 was harvested in 1mL of the RIPA buffer supplemented with 250µg of 
RNaseA and set 2 was harvested in 1mL of the RIPA buffer supplemented with 200 units 
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of RNase inhibitor. The lysate was then centrifuged at 10,000g for 10 minutes at 4 0C to 
separate out the cell debris. Then the supernatant after the centrifugation was used to 
perform FLAG-IP in a similar fashion as mentioned in section 2.7.  
2.9 eIF3F immunoprecipitation 
40µL of protein G DynabeadsTM (Invitrogen) was incubated with 1µg of eIF3F or PAIP1 
(negative control) specific antibody for 20 minutes at room temperature, followed by 1 
hour at 4 0C. Unbound antibody was washed with PBS and incubated with cell lysate 
prepared as mentioned above for FLAG-immunoprecipitation. The lysate and beads were 
incubated for 4 hours at 4 0C. Post incubation the beads were separated using a magnetic 
rack and washed with 500µL of 1XPBS. The wash step was repeated five times to avoid 
any false positive signals. Proteins bound to beads were eluted with 40µL of 2X 
concentration of Laemmli sample buffer and analyzed by Western blotting. 1% of the 
total lysate volume used for IP was used as input control during Western blot analysis. 
2.10 In vitro protein pull-down assay 
40µL of Glutathione Sepharose 4 Fast Flow affinity medium was equilibrated with 
TGEM (0.1) buffer (20mM Tris-HCl pH 7.9, 20% v/v glycerol, 1mM EDTA, 
5mM MgCl2, 0.1% v/v NP 40, 1mM DTT, 0.2mM PMSF, 0.1M NaCl). Purified 
recombinant proteins were quantified by the Bradford assay. The procedure for the 
Bradford assay was similar to the protocol mentioned in section 2.6. 500ng of the 
quantified bait protein (GST-eIF3F) was diluted to a final volume of 250µL in 
TGEM (0.1) buffer. The diluted sample was added to the equilibrated Glutathione 
Sepharose 4 Fast Flow affinity medium and incubated at 4 0C for 2 hours. The matrix was 
then washed once with ice cold TGEM (1.0) buffer (20mM Tris-HCl pH 7.9, 20% v/v 
glycerol, 1mM EDTA, 5mM MgCl2, 0.1% v/v NP 40, 1mM DTT, 0.2mM PMSF, 1M 
38 
 
NaCl) and twice with ice cold TGMC (0.1) buffer (20mM Tris-HCl pH 7.9, 20% v/v 
glycerol, 5mM CaCl2, 5mM MgCl2, 0.1% v/v NP 40, 1mM DTT, 0.2mM PMSF, 0.1M 
NaCl) to remove the unbound bait protein. 500ng of PDCD4 was diluted to a final 
volume of 50µL in TGMC (0.1) buffer and added to the matrix coated with the bait 
protein. The prey protein was incubated with the bait protein at 4 0C for 2 hours. The 
matrix was washed four times with TGEM (0.1) buffer to remove the unbound prey 
protein. The proteins bound to the matrix were eluted by addition of 2X concentration 
Laemmli Sample Buffer and heated at 98 0C for 5 minutes. 50ng of His-PDCD4 and 
eIF3F was loaded into 10% w/v SDS-PAGE along with the pull-down samples as 10% 
input control. Western blot analysis was then performed to identify the interaction 
between PDCD4 and eIF3F.  
2.11 Luciferase assay 
Cells were lysed in the lysis buffer provided in the renilla luciferase assay system 
(Promega). The lysate was centrifuged at 10,000g for 10 minutes to separate the cell 
debris. 10µL of the supernatant was added into 50µL of luciferase substrate in a 96 well 
plate and relative light unit (RLU) was measured using a BioTek® luminescence plate 
reader. 
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Chapter 3 
Results 
3.1 FLAG-IP to detect the interaction between eIF3 and PDCD4 
To investigate whether PDCD4 interacts with eIF3, I expressed FLAG-PDCD4 in the 
U343 cells and performed FLAG-IP. The proteins co-immunoprecipitated along with 
FLAG-PDCD4 were then analyzed by Western blotting. eIF3 is a dynamic complex of 13 
subunits and hence, it is possible that the PDCD4 could interact with the entire eIF3 
complex or one or more specific subunits of eIF3. Therefore, I probed the FLAG-IP blot 
with eIF3F, eIF3G, eIF3B, eIF3D, eIF3E, and eIF3H specific antibodies. As a result of 
this experiment, eIF3F, eIF3G, eIF3B, eIF3D, and eIF3E were found to be co-
immunoprecipitated with FLAG-PDCD4 (Figure 3.1). eIF3F, eIF3G, eIF3B, eIF3D, and 
eIF3E did not co-immunoprecipitate similarly with the FLAG-tag lysate, suggesting a 
specific interaction between FLAG-PDCD4 and eIF3 subunits (Figure 3.1). The band 
intensity of the eIF3H protein in the FLAG-PDCD4 IP and the FLAG-tag IP control was 
similar (Figure 3.1). This result suggests eIF3H non-specifically interacts with the FLAG-
tag or the affinity matrix (Figure 3.1). In addition to the eIF3H protein, a lower molecular 
weight protein was detected in the blot probed for eIF3H with anti-eIF3H mouse-raised 
antibody. This additional band corresponded to the molecular weight of mouse IgG from 
the anti-FLAG antibody used for FLAG-IP. 
Earlier work from Dr. Klempnauer’s group has shown that PABP interacts with PDCD4 
(Fehler et al., 2014). Hence, probing for PABP served as a positive control for the FLAG-
PDCD4 IP. On the other hand, PAIP1 is shown to interact with eIF3 and the PAIP1-eIF3 
interaction is regulated by S6K1. The PAIP1-eIF3 interaction has been demonstrated to 
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have a possible role in translation (Martineau et al., 2014). Hence, I probed the blot with 
PAIP1 specific antibody to check if PAIP1 is co-immunoprecipitated with FLAG-
PDCD4. As observed in the result, PAIP1 did not co-immunoprecipitate with FLAG-
PDCD4 or the FLAG-tag (Figure 3.1). 1% of the total cell lysate was analyzed to ensure 
the difference in the interaction between FLAG-PDCD4 and FLAG-tag lysates with eIF3 
was not due to the variation in eIF3 expression. The level of eIF3 subunits, PABP and 
PAIP1 were similar in the FLAG-tag and FLAG-PDCD4 expressing lysates (Figure 3.1). 
This further emphasizes the specificity of the interaction between FLAG-PDCD4 and 
eIF3 subunits. 
 
Figure 3.1: PDCD4 interacts with eIF3. 1% input from the total cell lysate was probed 
with antibodies against PDCD4, eIF3 subunits, PABP and PAIP1 (left panel). The level 
of eIF3 subunits, PABP and PAIP1 were similar in both the lysates. co-IP samples were 
probed with the same antibodies as the inputs. eIF3F, eIF3G, eIF3B, eIF3D, eIF3E and 
PABP were co-immunoprecipitated with FLAG-PDCD4 (right panel). There was no 
interaction between PAIP1 and FLAG-PDCD4. There was no enhanced pull down of the 
eIF3H subunit in the presence of FLAG-PDCD4 protein. Based on the molecular weight, 
the band indicated in the eIF3H co-IP could be the mouse IgG of the anti-FLAG antibody. 
This was detected as the secondary antibody used to detect eIF3H was an anti-mouse 
antibody. This image is a representation of the three repeats of the FLAG-IP.  
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3.2 eIF3F IP to detect the interaction between PDCD4 and eIF3F  
eIF3F has been reported to directly interact with S6K1 and aid phosphorylation of eIF3G 
(Martineau et al., 2014). Therefore, as the later objective was to study the effect of S6K1 
and 2 on eIF3-PDCD4 interaction. I chose to perform reciprocal IP with eIF3F antibody 
to further confirm the PDCD4-eIF3 interaction. The protein G DynabeadsTM were coated 
with anti-eIF3F antibody and used for eIF3F subunit IP from a 100-mm tissue culture 
dish. In the SDS-PAGE, the migration of the PDCD4 protein overlapped with the 
migration of the heavy chain of rabbit IgG antibody. Therefore, a conformation specific 
secondary anti-rabbit antibody raised in the mouse was used to detect PDCD4 and eIF3F 
instead of the Abcam anti-rabbit secondary antibody. 
In the reciprocal IP, PDCD4 was observed to be co-immunoprecipitated with the eIF3F 
subunit (Figure 3.2). When the co-IP blot was probed with an anti-PDCD4 antibody, an 
additional band of a higher molecular weight was observed along with PDCD4 in the 
eIF3F immunoprecipitated sample (Figure 3.2). The additional band observed could be 
the ubiquitinated form of PDCD4. PDCD4 is known to be degraded by the ubiquitin 
ligase-mediated mechanism (Dorrello et al., 2006). eIF3F may interact with post-
translationally modified and unmodified PDCD4 protein. Alternatively, PDCD4 
associated with eIF3F could be post-translationally modified by ubiquitination. The 
higher molecular weight protein was not observed in the input lanes. This suggests that 
the higher molecular weight protein has been enriched during the process of 
immunoprecipitation. PDCD4 was not detected in the lanes with elution from beads 
coated with non-specific antibodies (PAIP1) or lysates without FLAG-PDCD4 expression 
(Figure 3.2). As PDCD4 was not pulled-down with the non-specific antibody, these data 
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support the hypothesis that PDCD4 specifically interacts with the eIF3F subunit. 
However, endogenous PDCD4 was not detected in this experiment and this could be 
attributed to the low expression of PDCD4 in U343 cells. To circumvent this problem and 
to be able to perform endogenous PDCD4 IP, three other human glioblastoma cell lines 
were tested for PDCD4 expression. Of the different cell lines tested, SF767 and A172 
were found to have higher expression of PDCD4 in comparison to U343 (Figure 3.3). 
Therefore, these cell lines can be used to perform endogenous IP to study PDCD4-eIF3 
interaction. The current data on FLAG IP and reciprocal IP with eIF3F antibody indicate 
a specific interaction between eIF3F and PDCD4. 
 
Figure 3.2: eIF3F interacts with PDCD4. Reciprocal-IP performed using eIF3F antibody 
in U343 cell line (left panel). PDCD4 is co-immunoprecipitated along with eIF3F.  
PDCD4 was not detected when the IP was conducted with non-specific antibody (PAIP1) 
or the lysate without FLAG-PDCD4 protein (C). 1% input control for FLAG-PDCD4 and 
FLAG-tag containing lysates (right panel). The image is a representative image of the IP 
performed in duplicate.  
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Figure 3.3: PDCD4 protein levels are higher in S7F767 and A172 in comparison to the 
other cell lines. A) A Western blot assay was performed with 10µg of the total cell lysates 
obtained from 3X105 cells of different cell lines. The different cell lines used are 
indicated. The membrane was probed with anti-PDCD4 and anti-actin antibodies. The 
protein level of PDCD4 was higher in SF767 and A172 in comparison to U251N and 
U343 cells. B) Bar graph representing the densitometry values for the band intensity of 
PDCD4 normalized with their respective actin band intensity. This is a representation of a 
single experiment. 
 
3.3 Co-IP in the presence and absence of RNaseA to detect if the eIF3 and 
PDCD4 interaction is RNA-dependent 
The interaction of proteins demonstrated by IP can be a result of three major types of 
protein association in cells. In type I, PDCD4 and eIF3 may interact with the same RNA 
molecule without interfering with each other’s interactions. In type II, PDCD4 and eIF3 
can be a part a common protein complex and as a result be co-immunoprecipitated with 
each other. Lastly, in type III, PDCD4 and eIF3 subunits can directly interact with each 
other as depicted in the schematic diagram (Figure 3.4). 
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Figure 3.4: Schematic diagram representing the types of interactions detected by IP. The 
proteins detected in the IP assay could be a consequence of any one of the three types of 
interaction. P stands for PDCD4 in this schematic diagram. Firstly, PDCD4 and eIF3F 
can be interacting to the same RNA molecule with no interaction with each other 
(Type I). Secondly, PDCD4 and eIF3F may be a part of a common protein complex 
(Type II). Lastly, the two proteins could directly interact with each other (Type III). 
 
To identify if the interaction between PDCD4 and eIF3 was mediated by an RNA 
molecule, FLAG IP was performed with RNaseA-treated lysates. eIF3F and eIF3D were 
co-immunoprecipitated with FLAG-PDCD4 in both RNaseA-treated and RNaseA-
untreated samples (Figure 3.5). This suggests that PDCD4 interacts with eIF3F and eIF3D 
in an RNA-independent manner. There was no effect on the protein levels of PDCD4 
upon RNaseA treatment as observed from the Western blot image of 1% total lysate 
(Input, Figure 3.5). The protein levels of eIF3F and eIF3D were similar in all four lysates 
as seen in the input blot (Figure 3.5). PDCD4 protein was not detected in the FLAG tag 
control lysate (Figure 3.5). Also, there was no significant interaction of eIF3 subunits 
with FLAG-tag or the matrix used for IP. To conclude, this data demonstrates that the 
PDCD4-eIF3F and PDCD4-eIF3D interaction is specific and RNA-independent. 
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Figure 3.5: The PDCD4-eIF3 interaction is RNA-independent. 1% input from the total 
cell lysate was analyzed to compare the protein levels upon different treatment (left 
panel). Similar levels of eIF3 subunits were observed across samples. PDCD4 was below 
detectable levels in lysate from cells transfected with the pcDNA3-FLAG plasmid. 
PDCD4 was co-immunoprecipitated with eIF3 subunits (right panel). There was no 
difference in interaction upon RNaseA treatment. This indicates that the interaction 
between PDCD4 and eIF3 is not dependent on RNA. 
 
3.4 Optimization of recombinant protein purification 
The PDCD4-eIF3 interaction is RNA-independent, however, it is unclear whether this is a 
direct or an indirect interaction. These two types of interactions can be differentiated by 
in vitro protein pull-down. To perform this assay, His-PDCD4, GST-eIF3F, and GST 
expressing plasmids were obtained from the labs as mentioned in table 2.1. 
The sequence of the gene inserted in the plasmid was confirmed by sequencing. A varied 
concentration of IPTG was investigated to optimize the protein purification as mentioned 
in section 2.4. Based on the results from the Coomassie-stained gels, the intensity of a 25 
kDa protein band was increased upon IPTG induction for E. coli DE3 transformed with 
GST expression plasmid (Figure 3.6B). The band intensity did not vary with 0.5mM and 
1mM IPTG concentration and hence a final concentration of 0.5mM IPTG was used for 
further purification of GST protein (Figure 3.6B). The band pattern of the proteins in the 
eIF3F
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pcDNA3-PDCD4-FLAG + - + - + - + -
RNaseA + + - - + + - -
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SDS-PAGE was analyzed to check for the induction of proteins. The protein band pattern 
in the bacterial lysates from E. coli transformed with His-PDCD4 and GST-eIF3F 
plasmids were similar in both un-induced as well a culture induced with varying 
concentration of IPTG. However, the protein profile varied across samples transformed 
with different expression constructs. When compared to the protein standard, migration of 
the proteins indicated in Figure 3.6 corresponds to the molecular weight of His-PDCD4 
(52kDa, Figure 3.6B) and GST-eIF3F (62 kDa, Figure 3.6A).  This led to the speculation 
that the bands indicated in Figure 3.6 could be of His-PDCD4 and GST-eIF3F proteins. 
The GST-eIF3F expressing bacterial lysates were run along with GST-PDCD4 expressing 
bacterial lysates (Figure 3.6A). The 62 kDa band observed in the GST-eIF3F expressing 
bacterial lysate was not observed in the GST-PDCD4 expressing lanes. Instead, a band of 
about 75 kDa corresponding to GST-PDCD4 was observed (Figure 3.6A). The 
Coomassie-stained gels did not show any enhanced expression with the addition of IPTG. 
The vector backbone of these recombinant plasmids may not code for lac repressor and 
result ina leaky expression of the gene. Further confirmation of the proteins expressed 
was done prior to the in vitro pull-down assay. 
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Figure 3.6: Coomassie staining to detect protein induction. A) BL21 DE3 strains as 
mentioned in section 2.2 were transformed with GST-PDCD4 and GST-eIF3F plasmid 
was induced at varying concentration of IPTG for 3 hours at 37 0C. No change in protein 
profile between the un-induced and induced was observed. However, the band indicated 
by an arrow was unique in the GST-PDCD4 and GST-eIF3F lanes. The molecular 
weights of the bands indicated correspond to the GST-PDCD4 and GST-eIF3F proteins. 
B) Similar to panel A, the unique bands in the cell lysates are indicated for His-PDCD4 
and GST protein. The molecular weights of the indicated bands correspond to the 
molecular weights of the His-PDCD4 and GST proteins. 
 
3.5 Western blotting to confirm His-PDCD4 and GST-eIF3F expression 
Coomassie staining detects all the proteins in the cell lysate. The proteins can be 
differentiated from one another only based on their molecular weight or migration 
properties in SDS-PAGE. To confirm if the indicated bands in Coomassie-stained gels 
(Figure 3.6) corresponds to PDCD4 and eIF3F, a Western blot assay was performed.  
Lysates were prepared as for the Coomassie staining experiment. However, as the 
Western blot technique is more sensitive in comparison to Coomassie staining, the 
samples were diluted by 10-fold or 100-fold and analyzed as in the case of Figure 3.7B. 
In Figure 3.7A, 10-fold diluted samples were loaded for analysis. In Figure 3.7A, un-
induced and induced samples with a final concentration of 0.1mM, 0.5mM, and 1mM 
IPTG were analyzed on SDS-PAGE followed by Western blot. The nitrocellulose 
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membrane was probed with a PDCD4-specific antibody. PDCD4 protein was detected in 
the un-induced as well as in the induced E. coli cultures (Figure 3.7). PDCD4 was 
detected in the cell lysate with His-PDCD4 plasmid and not in the lysate obtained from 
the bacteria transformed with the GST expression construct (Figure 3.7). This confirmed 
the His-PDCD4 expression in the E. coli BL21 DE3 culture. In Figure 3.7B, BL21 DE3 
strains transformed with the GST-PDCD4 (BL21 DE3) and GST-eIF3F (BL21 DE3 
ROSETTA 2 PLYSS) expression constructs as well as cells without any expression 
construct were investigated for protein expression. The membrane was probed with the 
anti-eIF3F antibody. eIF3F protein was detected in both induced and un-induced culture 
lysates of the bacteria with GST-eIF3F plasmid, and not in the bacteria without any 
plasmid or bacteria with a GST-PDCD4 plasmid. This confirmed the expression of His-
PDCD4 and GST-eIF3F in E. coli.  
 
Figure 3.7: Western blot assay to confirm protein expression. A) PDCD4 protein was 
detected in the lysates with the His-PDCD4 plasmid. PDCD4 was not observed for lysates 
from bacteria with GST expression plasmid. B) eIF3F was specifically detected in the 
bacterial lysates with GST-eIF3F expression plasmid. These results confirm the 
expression of His-PDCD4 and GST-eIF3F. 
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3.6 In vitro pull-down of GST-tagged protein to detect direct interaction between 
PDCD4 and eIF3F 
As mentioned earlier, to investigate if PDCD4 can directly interact with eIF3F, in vitro 
pull-down was performed using glutathione sepharose matrix. The assay was performed 
as mentioned in section 2.8. Western blot analysis of the pulled-down protein was 
performed using anti-eIF3F and anti-PDCD4 antibody. His-PDCD4 was detected in the 
presence of GST-eIF3F but not with GST or glutathione sepharose matrix (Figure 3.8). 
These results suggest direct protein-protein interaction between eIF3F and PDCD4. 
 
Figure 3.8: PDCD4 directly interacts with eIF3F.The proteins were separated on SDS-
PAGE and was analyzed by Western blotting using specific antibodies. His-PDCD4 was 
observed to be pulled-down with GST-eIF3F and not with GST or only glutathione 
sepharose matrix. 
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3.7 Co-IP in S6K wild-type and knockout MEFs 
PDCD4 and eIF3G subunits are post-translationally modified by S6K1 and 2 (Dennis et 
al., 2012; Liwak et al., 2012; Martineau et al., 2014). As mentioned in section 1.3.2 post-
translation modification can affect the function and intermolecular interactions of the 
protein (Duan & Walther, 2015). Therefore, S6K1 and/or 2-mediated modifications of 
PDCD4 or eIF3G subunits could have an effect on the PDCD4-eIF3 interaction. To test if 
S6K1 and/or 2 have any role in the PDCD4-eIF3 interaction, FLAG-IP was performed in 
the S6K1 and 2 double knockout MEFs. S6K1 and 2 double knockout MEFs lacked S6K1 
and 2 activity, which was confirmed by investigating the phosphorylation status of theS6 
protein. The S6 protein is phosphorylated by S6K1 and 2 and this was detected using S6 
and pS6 specific antibodies. As expected, phosphorylation of S6 was not detected in the 
S6K double knockout cell line (Figure 3.9). This confirmed the absence of S6K1 and 2 
activity in the S6K knockout cell line. 
 
Figure 3.9: Phosphorylation of S6 is not detected in S6K double knockout MEFs. S6 
protein was equally expressed in wild-type and knockout. Phosphorylation of S6 was not 
observed in the S6K double knockout. 
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To check if PDCD4 and eIF3F interact in the S6K1 and 2 double knockout background, 
FLAG-PDCD4and FLAG-tag were expressed in S6K1 and 2 expressing MEFs (wild-
type) and S6K1 and 2 double knockout MEFs. After 48 hours of transfection, the cells 
were lysed and an equal volume of the lysate was used to perform FLAG-IP followed by 
Western blot. The membrane was probed with anti-PDCD4, anti-eIF3F, anti-S6 and anti-
pS6 antibodies. 
There was no detectable difference in the level of co-immunoprecipitated eIF3F in 
FLAG-PDCD4 and FLAG-tag expressed MEFs (Figure 3.10). Interestingly, pS6 was 
found to be co-immunoprecipitated with FLAG-PDCD4 in the S6K wild-type cell lysate. 
However, this interaction of PDCD4 with pS6 has not been reported earlier and needs to 
be validated. On the other hand, S6 protein did not show an interaction with FLAG-
PDCD4 either in the S6K wild-type or in the knockout MEFs (Figure 3.10). PDCD4, 
eIF3F, and S6 had similar levels of expression in all the samples. pS6 was not observed in 
the knockout MEFs due to the absence of S6K1 and 2 activity. This suggests that the 
interaction between PDCD4 and eIF3 may not occur in these MEFs. Therefore, S6K1 
and 2 double knockout and wild-type MEFs may not be suitable to test the effect of S6K1 
and 2 on the PDCD4-eIF3 interaction as there was no PDCD4-eIF3 interaction detected 
in these cells. 
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Figure 3.10: PDCD4 and eIF3 do not interact in MEFs. PDCD4, eIF3F and S6 protein 
levels were similar in all four input lanes (left panel). pS6 was not observed in the S6K 
knockout cell line. The absence of S6 phosphorylation further confirms the absence of 
S6K1 and 2 activity in the cell line. In the co-IP lanes, eIF3F band intensity was similar in 
all four lanes, indicating no specific interaction with PDCD4 (right panel). 
 
3.8 FLAG-IP during serum starvation 
mTORC1 is inhibited in the absence of growth factors. Hence, mTORC1 activity is 
blocked during serum starvation (R. Chen et al., 2014). Lack of mTORC1 activity inhibits 
the downstream activation of S6K1 and 2 (Holz et al., 2005). Thus, I conducted FLAG-IP 
in the serum starvation condition to study the effect of S6K1 and 2 on PDCD4-eIF3 
interaction. Inhibition of S6K1 and 2 activity in U343 after 24 hours of serum starvation 
was tested by immunoblotting. Upon serum starvation, reduced phosphorylation of S6 
protein was observed in U343 (Figure 3.11). The expression of S6 protein remained 
unaffected during serum starvation. This indicates that the decrease in the phosphorylated 
form of S6 is due to the loss in S6K1 and 2 activity. 
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Figure 3.11: Serum starvation inhibits S6K1 and 2 activity. Protein level of S6 was not 
affected. The level of the phosphorylated form of S6 decreased with serum starvation.   
 
pS6 and eIF3F were found to co-immunoprecipitate with FLAG-PDCD4 (Figure 3.12A). 
The eIF3F-PDCD4 interaction was found to be decreased by about 25% in serum-starved 
condition when normalized with the amount of PDCD4 immunoprecipitated 
(Figure 3.12B). However, there was a decrease in the levels of eIF3F upon serum 
starvation. The decrease in PDCD4-eIF3F interaction observed could be due to the 
decrease in eIF3F protein level and not the difference in the PDCD4-eIF3F interaction. 
Similarly, a decrease in the PDCD4-pS6 interaction was seen and this also is likely due to 
a decrease in the phosphorylation of S6 upon serum starvation (Figure 3.12A).   
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Figure 3.12: ThePDCD4-eIF3F interaction is not affected by serum starvation. A) eIF3F 
and pS6 were co-immunoprecipitated with PDCD4. This interaction decreased with 
serum starvation. However, the input lanes indicated a decrease in eIF3F and pS6 protein 
levels in the total cell lysate. This suggests there may not be anet difference in the 
PDCD4-eIF3F interaction during serum starvation. B) The amount of eIF3F 
immunoprecipitated from 3 independent experiments was normalized to PDCD4 pull- 
down and plotted as a fold change. C) Tabulation of the fold change values calculated for 
PDCD4-eIF3F interaction during serum starvation in comparison to the control. The 
eIF3F band intensity was normalized to the amount of PDCD4 pull-down. Then the 
control was normalized to one and the fold change during serum starvation was calculated 
in comparison to the control.  
 
3.9 Luciferase reporter assay to investigate the role of eIF3F in cap-dependent 
translation 
We do not know how the PDCD-eIF3F interaction would impact on global and transcript-
specific translation. In order to identify the role of PDCD4-eIF3F interaction, it is first 
important to understand the independent role of eIF3F and PDCD4 on translation. The 
eIF3F subunit and PDCD4 can have a positive or negative effect on mRNA translation. In 
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order to investigate their specific role in cap-dependent translation in U343, a luciferase 
reporter assay was conducted in conjunction with the partial knockdown of eIF3F or 
PDCD4. The partial knockdown of eIF3F and PDCD4 was achieved by treating cells with 
siRNA specifically targeting eIF3F and PDCD4 mRNAs. The protein levels of eIF3F and 
PDCD4 after silencing were examined by the Western blotting assay. The Western blot 
data showed a decrease in eIF3F and PDCD4 level in comparison to the cells treated with 
non-specific siRNA (Figure 3.13B). Upon confirmation of partial knockdown, luciferase 
reporter assay was conducted with the same lysates. Partial silencing of eIF3F in U343 
decreased cap-dependent translation by about 25%. There was no effect on the cap-
dependent translation due to the partial knockdown of PDCD4 mRNA expression (Figure 
3.13A). The decrease in luciferase expression was calculated in comparison to the cells 
treated with non-specific siRNA. Hence, the reduction of luciferase expression is a direct 
result of the loss of eIF3F protein and not an artifact of siRNA treatment. These results 
confirm the importance of eIF3F in cap-dependent translation.   
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Figure 3.13: Partial knockdown of eIF3F decreases cap-dependent translation.  A) The 
luciferase readings obtained for every experiment were normalized with their respective 
total protein concentrations. The normalized RLUs were compared with the values for the 
cells treated with non-specific siRNA to derive the fold change in RLUs as represented. 
The average fold change of three independent experiments demonstrates a 25% decrease 
in luciferase expression upon eIF3F knockdown. B) Western blot to confirm partial 
knockdown of PDCD4 and eIF3F. The blots indicate more than 50% knockdown of 
eIF3F and PDCD4 proteins. C) Tabulation of the fold change values calculated for 
luciferase activity upon partial silencing of PDCD4 and eIF3F in comparison to the 
control. The control was normalized to one and the fold change during test conditions was 
calculated in comparison to the control.  
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Chapter 4 
Discussion 
4.1 Discussion 
Genomic DNA, mRNAs, and proteins are the three key regulatory molecules in 
eukaryotic cells.  These three are the indispensable components of the molecular biology 
central dogma. DNA is transcribed into mRNA which is then translated into protein.  
Each of these steps is regulated to control the gene expression as per the cell 
requirements. For example, there are several biological factors affecting the efficiency of 
transcription like promoter sequence, transcription factors, RNA polymerases, cytokines, 
and epigenetic modifications (T. I. Lee & Young, 2013). mRNA thus transcribed relies on 
eIFs, cis-acting elements, mRNA trans-acting factors, availability of tRNAs and 
ribosomes, along with many other cellular factors (Hershey, Sonenberg, & Mathews, 
2012). Therefore, it is a time and energy consuming process for the cells to start with 
transcription every time that it requires a protein. In case of stress, it is observed that the 
mRNA profile of the cell does not match with the proteome profile of the cell (Cheng et 
al., 2016; Lackner, Schmidt, Wu, Wolf, & Bahler, 2012; Liu, Beyer, & Aebersold, 2016). 
This observation could be a result of the altered protein stability. Moreover, this could 
also indicate that the cell strategically regulates the translation of the available mRNAs to 
conserve energy. In order to enhance the mRNA translation, it utilizes beneficial trans-
acting factors, eIFs, alternative translation initiation mechanism or increases mRNA 
stability (Cheneval, Kastelic, Fuerst, & Parker, 2010; Hershey et al., 2012; Nevins, 
Harder, Korneluk, & Holcik, 2003). While to decrease protein expression, the cell 
reduces the mRNA stability, forms P-bodies, employs small and long non-coding RNAs 
to degrade or suppress mRNA expression, cleaves eIFs, sequesters eIFs or stabilizes 
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trans-acting factors with an adverse effect on mRNA expression (Cheneval et al., 2010; 
Hershey et al., 2012). Investigating these post-transcriptional regulations is critical as they 
could be the immediate option for the cells during any stress condition.  
The mTOR pathway is a classical example that is extensively studied for post-
transcriptional or translation regulation. PDCD4 and eIF3 studied in this project are the 
targets of the mTOR pathway (Laplante & Sabatini, 2009). They are phosphorylated by 
S6K1 and/or 2, a downstream target of mTORC1 (Laplante & Sabatini, 2009). PDCD4 
phosphorylation promotes PDCD4 degradation while eIF3 phosphorylation enhances 
eIF3 activity (Laplante & Sabatini, 2009; Martineau et al., 2014). Degradation of PDCD4 
and phosphorylation of eIF3 enhances the translation of target mRNAs. One of the known 
common target mRNAs for PDCD4 and eIF3 is XIAP mRNA (Liwak et al., 2012; Thakor 
et al., 2017). PDCD4 and eIF3 directly interact with the XIAP mRNA with opposite 
effects on XIAP mRNA translation (Liwak et al., 2012; Thakor et al., 2017). Hence, as 
mentioned earlier, I wanted to investigate if there is an interaction between PDCD4 and 
eIF3 because this could be a possible mechanism of repressing XIAP or any other target 
mRNA expression.  
The results of my experiments demonstrate a specific RNA-independent interaction 
between PDCD4 and the eIF3 complex. eIF3 is a 13-subunit complex (Hershey, 2015) 
and of the 13 subunits, eIF3B, eIF3D, eIF3E, eIF3G, and eIF3F subunits were shown to 
interact with PDCD4 in the co-IP I performed. Based on my results, I hypothesized that 
the co-immunoprecipitation of these eIF3 subunits could be a result of three types of 
interactions. i) PDCD4 interacts with the eIF3 complex and therefore multiple eIF3 
subunits were co-immunoprecipitated with PDCD4. The PDCD4-eIF3 interaction could 
inhibit eIF3 association with the mRNA or other cellular proteins and thereby inhibit 
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translation. ii) eIF3 may be present as subcomplexes that do not contain all the 13 
subunits. eIF3 could consist of a core complex made up of specific subunits and the 
remaining subunits may be involved only in regulatory mechanisms (Hershey, 2015). 
PDCD4 may interact with subcomplex that include eIF3B, eIF3D, eIF3E, eIF3G, and 
eIF3F subunits to inhibit translation. iii) PDCD4 may directly interact with each of the 
subunits as demonstrated for eIF3F in this project. The interaction of PDCD4 with one of 
the subunits could either block its association with other eIF3 subunits to form the 
functional complex or inhibit its independent activity.   
eIF3F, which is shown to bind PDCD4 in my experiments, has also been earlier reported 
to interact with S6K1 (Martineau et al., 2014). The eIF3F and S6K1 interaction was 
demonstrated by an in vitro experiment (Martineau et al., 2014). S6K1 binds to eIF3F in 
order to phosphorylate the eIF3G present in the eIF3 complex (Martineau et al., 2014). 
However, the in cellulo experiments suggested that both the S6K1 and 2 have a role in 
eIF3 phosphorylation (Martineau et al., 2014). PDCD4 interacting with eIF3F can 
interfere with eIF3F and S6K1/2 association to prevent phosphorylation of the eIF3 
complex. Similarly, PDCD4 binding to eIF3B and eIF3E can affect their function to 
interact with eIF4G and inhibit ribosome recruitment to the mRNA. Additionally, eIF3B 
is essential for mRNA recruitment and eIF3D can bind to the cap structure (Hinnebusch, 
2006; A. S. Lee, Kranzusch, Doudna, & Cate, 2016). These canonical and specialized 
functions of the eIF3 subunits can be affected by its interaction with PDCD4. Besides 
eIF3, PDCD4 is known to interact with PABP and eIF4A to suppress their role in 
translation and downregulate protein synthesis (Fehler et al., 2014; Suzuki et al., 2008). 
Therefore, I believe that the PDCD4-eIF3 interaction will also have a similar effect and 
inhibit translation.  
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In cells, the protein-protein interactions can be regulated by post-translational 
modifications. There are different types of post-translational modifications and 
phosphorylation of proteins is one among them (Prabakaran, Lippens, Steen, & 
Gunawardena, 2012). Phosphorylation of proteins can alter the charge, structure and 
binding affinity of the proteins (Nishi, Hashimoto, & Panchenko, 2011). This particular 
protein modification is commonly executed by kinases (Nishi et al., 2011). Interestingly, 
both PDCD4 and eIF3 are phosphorylated by S6K1 and/or 2 (Dennis et al., 2012; 
Martineau et al., 2014). Therefore, it is possible that the PDCD4 and eIF3 interaction can 
be affected by the activation of S6K1 and/or 2. To validate this hypothesis, I tested if 
inhibiting S6K1 and/or 2 activity would affect PDCD4 and eIF3 interaction. 
To inhibit the S6K1 and 2 activity, cells were incubated with serum-free media for 24 
hours. Most likely, mTORC1 and its downstream target S6K1 and 2 were inhibited in the 
absence of growth factors. eIF3F was equally co-immunoprecipitated with PDCD4 from 
cells incubated with serum-free media or media containing 10% v/v serum. This implies 
that S6K1 and/or 2 activity do not affect the PDCD4-eIF3F interaction (Figure 3.12). 
However, treatment with serum-free media could trigger multiple effects besides S6K1 
and 2 inhibition. It is important to perform similar co-IP experiments using chemical 
inhibitors that specifically target S6K1 and 2 activity. This result of eIF3F and PDCD4 
interaction during serum-starved condition may not be extrapolated to all the eIF3 
subunits, as the interaction between each of the eIF3 subunit and S6Ks may vary 
(Martineau et al., 2014). Apart from S6K, other kinases such as cyclin-dependent kinase 
11 can phosphorylate eIF3F (J. Shi, Hershey, & Nelson, 2009). Such phosphorylation 
may also affect the PDCD4-eIF3F interaction. To conclude, the PDCD4-eIF3F interaction 
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is not affected by serum starvation and further testing needs to done to study the effect of 
S6K-independent phosphorylation on the PDCD4-eIF3F interaction.  
In addition to eIF3 subunits, for the first time, I observed the interaction of pS6 with 
PDCD4. pS6 is a part of translating 40S ribosomes (Biever, Valjent, & Puighermanal, 
2015) and interaction with PDCD4 can inhibit translation initiation. The interaction was 
not tested in the lysates treated with RNaseA and thus the pS6 co-immunoprecipitated 
with PDCD4 could be a result of an RNA-dependent or an RNA-independent interaction. 
Further investigations need to be conducted to validate the pS6 and PDCD4 interaction. 
In general, PDCD4 appears to interact with eIFs or trans-acting factors to sequester them 
and inhibit translation.  
PDCD4 is characterized as a translation inhibitor while its interacting partner eIF3F has 
contradictory reports of promoting and inhibiting translation (Gutierrez-Fernandez, 
Higareda-Mendoza, Gomez-Correa, & Pardo-Galvan, 2015; Liwak et al., 2012; Wen et 
al., 2012). eIF3F is shown to interact with mTORC1 and activate S6K1 in skeletal muscle 
cells (Csibi et al., 2010). The activation of S6K1 in muscle cells leads to increased protein 
synthesis (Csibi et al., 2010). Similarly, the eIF3F protein level was established to peak in 
the S phase and mitosis of the A549 cell cycle to enhance cell proliferation (Higareda-
Mendoza & Pardo-Galvan, 2010). Conversely, partial silencing of eIF3F in a human 
pancreatic cell line promoted cap-dependent and cap-independent translation (Wen et al., 
2012). As the eIF3F subunit can either have a positive or a negative effect on translation 
depending on the cell line. I wanted to identify if the eIF3F subunit had a positive or an 
inhibitory effect on translation in U343 cells. Therefore, I partially silenced eIF3F and 
checked the expression of a luciferase reporter construct. A reduction in luciferase 
expression was observed reflecting the positive role of eIF3F in luciferase expression 
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likely at the translational level. Alongside eIF3F, I also performed a similar experiment 
with PDCD4 to check its role in the cap-dependent translation in U343 cells. PDCD4 was 
showed to inhibit cap-dependent translation (Suzuki et al., 2008; H. S. Yang et al., 2003). 
However, there was no effect on the luciferase expression upon a partial silencing of 
PDCD4. This observation was probably due to the type of luciferase construct used in this 
experiment. PDCD4 is known to interact with eIF4A and preferentially inhibit the cap-
dependent translation of the mRNAs containing a structured 5’ UTR (H. S. Yang et al., 
2004). The pRL-CMV construct used in this experiment does not have a long structured 
5’ UTR. Thus, it may not require eIF4A for its expression and therefore is not inhibited 
by PDCD4. 
The results of the luciferase assay conducted in the U343 cells suggest that eIF3F has a 
positive role likely in the cap-dependent translation. Based on the literature, the eIF3 
complex is an essential component of both cap-dependent and independent initiation 
process (Cate, 2017; Thakor et al., 2017). Therefore, the interaction between PDCD4 and 
eIF3 subunits can potentially inhibit most translating mRNAs. This mechanism may have 
a regulatory role during stress conditions when a subset of mRNAs is translated by an 
IRES-mediated mechanism.  
4.2 Future directions 
4.2.1 Short-term vision 
eIF3 and PDCD4 are known to interact with multiple cellular mRNAs (A. S. Lee, 
Kranzusch, & Cate, 2015; Liwak et al., 2012). XIAP mRNA is a common target for the 
binding of eIF3 and PDCD4 (Figure 4.1). XIAP is an anti-apoptotic protein. Studying the 
effect of the PDCD4-eIF3 interaction on XIAP mRNA translation will help us obtain 
further details on cell proliferation during stress.  All the 13 subunits of eIF3 may not 
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interact with XIAP mRNA. eIF3A, eIF3B, and eIF3C are involved in mRNA recruitment 
and hence are the most likely candidates to interact with XIAP mRNA. It will be 
interesting to identify the specific eIF3 subunits interacting with XIAP mRNA and 
PDCD4. Identifying the eIF3 subunit interacting with PDCD4 will give us information on 
the probable function of eIF3 inhibited by PDCD4. The data on eIF3 subunit interacting 
with XIAP mRNA will help us understand the role of eIF3 in XIAP mRNA translation. 
After obtaining the information on eIF3 subunit interaction with XIAP mRNA, the 
nucleotides in the XIAP mRNA interacting with eIF3 subunits and PDCD4 can be 
identified by a toeprinting assay. This will tell us if it is possible that PDCD4 and eIF3 
subunits compete with each other for the binding site on XIAP mRNA and inhibit each 
other’s function. Alongside the toeprinting assay, a UV crosslinking assay could be 
performed to investigate if the binding of one protein affects the interaction of the other to 
the XIAP mRNA. These experiments will be able to give us an idea of the significance of 
the PDCD4-eIF3 interaction on XIAP mRNA translation. This mechanism can be 
extrapolated and validated for other target cellular mRNAs. 
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Figure 4.1: Schematic representation of the eIF3 and PDCD4 downstream targets. The 
mTORC1 activates S6K1 and 2, which then activates eIF3 and inhibits PDCD4. eIF3 
enhances the cap-dependent translation and XIAP IRES-mediated translation. PDCD4 
inhibits the XIAP IRES-mediated translation and general cap-dependent translation. 
 
PDCD4 has been extensively studied for its tumor suppressor activity and more recently 
for its role in lipid metabolism and insulin resistance (Ding et al., 2016; Ferris et al., 
2011; Lankat-Buttgereit & Goke, 2009; Vikhreva, Shepelev, Korobko, & Korobko, 
2010). Besides PDCD4, eIF3 has also been shown to participate in mechanisms related to 
metabolism (Shah et al., 2016). Therefore, it is possible that the PDCD4-eIF3 interaction 
can have an effect beyond apoptosis-related mRNAs. It would be interesting to identify 
all the cellular mRNAs interacting with PDCD4 by UV-CLIP followed by sequencing. 
The sequencing results thus obtained can be compared with the list of cellular mRNAs 
shown to interact with eIF3 by Dr. Jamie Cate’s research group (A. S. Lee et al., 2015). 
By doing so, we can identify the common pool of cellular mRNAs regulated by PDCD4 
and eIF3. This will provide leads to establish the common role of the PDCD4-eIF3 
interaction on mRNA expression. 
  
mTORC1
S6K1 and 2
PDCD4 eIF3
XIAP IRES-mediated translation
Cap-dependent 
translation
Bcl-xL IRES-mediated translation
eIF4A
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4.2.2 Future-oriented outlook 
eIF3 subunits and PDCD4 have been shown to promote and inhibit cell proliferation in 
glioblastoma (Hao, Liang, & Jiao, 2015; Sesen et al., 2014; Wang, Wang, Tang, & To, 
2015). The roles of these proteins in different stages of cancer are not clear. Hence, it will 
be interesting to study the translatome profile of specific eIF3 subunits and PDCD4 in the 
different stages of cancer. To study the translatome profile, the specific eIF3 subunit or 
PDCD4 can be partially silenced. After partial silencing of the specific protein, mRNAs 
associated with the actively translating ribosomes can be isolated and sequenced. mRNAs 
thus identified in the partially silenced samples can be compared to the control to identify 
the set of mRNAs that are affected by the reduction of eIF3 subunit or PDCD4 protein 
levels. Comparison of these profiles across different stages of cancer will provide us 
information on the mRNA translation regulated by eIF3 subunits and PDCD4 in the 
different stages of cancer. This will add to our understanding of translation regulation 
during cancer progression and the knowledge can be employed in designing therapeutics.  
In recent times, eIFs that are a part of the eIF4F complex have been targeted for cancer 
therapy (Bhat et al., 2015; Pelletier et al., 2015). Similarly, eIF3 subunits and PDCD4 can 
also be looked into as targets for cancer therapy. To begin with, the preliminary 
information about eIF3 and PDCD4 obtained from glioblastoma cells has to be validated 
in a mouse model. To study the importance of eIF3 subunits and PDCD4 in glioblastoma 
progression, cancerous cells with compromised expression of eIF3 subunits and PDCD4 
can be grafted into the mouse. The proliferation of the grafted cells can be monitored and 
compared with the grafted wild-type or control cells to pinpoint the significance of eIF3 
and PDCD4 in glioblastoma. The eIF3 and PDCD4 are a target of the mTOR pathway 
and regulated by S6K1 and 2 (Laplante & Sabatini, 2012). Therefore, mTOR inhibitors or 
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S6K1 and 2 inhibitors can beused in combination with knockdown of eIF3 subunits 
and/or PDCD4 to monitor cancer progression.  
Glioblastoma is one of the hard-to-treat cancers, therefore it is important to explore 
alternative strategies such as targeting the translation machinery or regulators of 
translation.  Therefore, these studies will have an impact on our current understanding of 
translation control during cell death and metabolism that can be deployed in formulating 
new cancer therapy. 
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